Breaking News

Over a week ago Show Full Stories X To view all stories in expanded form, please subscribe. Get Free Trial Send Info
Options	Early notable gainers among liquid option names on May 22nd » 09:55 05/22/20 05/22 09:55 05/22/20 09:55 NEM Newmont $63.90 / +0.37 (+0.58%) , NVDA Nvidia $350.67 / -0.34 (-0.10%) , BSX Boston Scientific $35.53 / +0.72 (+2.07%) , SIG Signet Jewelers $10.20 / +0.04 (+0.39%) , A Agilent $87.10 / +6.26 (+7.74%) Notable gainers among… Notable gainers among liquid option names this morning include Agilent (A) $86.70 +5.95, Signet Jewelers (SIG) $10.58 +0.42, Boston Scientific (BSX) $35.89 +1.10, NVIDIA (NVDA) $358.58 +7.57, and Newmont Mining (NEM) $64.72 +1.24. ShowHide Related Items >><< Company News Street Research Earnings Syndicate Periodicals On The Fly Events Options SIG NVDA NEM BSX A SIG Signet Jewelers $10.20 / +0.04 (+0.39%) 04/01/20 Signet Jewelers downgraded to B at Fitch Ratings; outlook negative 03/26/20 Signet Jewelers up 9% to $8.00 after Q4 results beat estimates 03/26/20 Signet Jewelers reports Q4 gross margin 41.7% of sales, up 100 bps y/y 03/26/20 Signet Jewelers reports Q4 e-commerce sales up 15.1% y/y NVDA Nvidia $350.67 / -0.34 (-0.10%) 05/21/20 Nvidia CFO says gaming hours played on GeForce platform rose 50% 05/21/20 Nvidia CEO says Cloud computing journey has long way to go 05/21/20 Nvidia down 1% at $347.50 per share after Q1 earnings 05/21/20 Nvidia reports Q1 Gaming revenue up 27% from last year at $1.34B NEM Newmont $63.90 / +0.37 (+0.58%) 05/13/20 Newmont to begin ramping up operations at Penasquito mine, Mexico 05/05/20 Newmont says 'well positioned' to ramp-up mining operations 04/21/20 Newmont raises quarterly dividend to 25c per share from 14c per share 03/31/20 Newmont completes sale of Red Lake complex BSX Boston Scientific $35.53 / +0.72 (+2.07%) 05/15/20 Third Point adds Disney, exits Campbell Soup in Q1 05/08/20 Boston Scientific' Emblem defibrillator system meets primary endpoint 05/08/20 Boston Scientific' Watchman device meets safety and efficacy endpoints 04/23/20 UnitedHealth, Boston Scientific, Medtronic to deploy 3,000 ventilator devices A Agilent $87.10 / +6.26 (+7.74%) 05/21/20 Agilent up 5% to $84.70 after Q2 results beat estimates 05/18/20 Agilent PD-L1 assay receives FDA approval for use as companion diagnostic 05/15/20 Ackman's Pershing Square adds Blackstone, cuts Chipotle in Q1 05/15/20 FDA approves Agilent PD-L1 diagnostic device for lung cancer NEM NVDA BSX SIG A NEM Newmont $63.90 / +0.37 (+0.58%) 05/18/20 Standpoint Research Newmont downgraded to Hold from Buy at Standpoint Research 05/06/20 Deutsche Bank Newmont price target raised to $70 from $54 at Deutsche Bank 05/06/20 Citi Newmont price target raised to $70 from $46 at Citi 04/16/20 JPMorgan Newmont price target raised to $70 from $61 at JPMorgan NVDA Nvidia $350.67 / -0.34 (-0.10%) 05/22/20 JPMorgan Nvidia price target raised to $405 from $305 at JPMorgan 05/22/20 Rosenblatt Nvidia price target raised to $400 from $340 at Rosenblatt 05/22/20 Raymond James Nvidia price target raised to $370 from $330 at Raymond James 05/22/20 Craig-Hallum Nvidia price target raised to $335 from $300 at Craig-Hallum BSX Boston Scientific $35.53 / +0.72 (+2.07%) 05/10/20 Piper Sandler FLX to further strengthen Boston category leadership in LAAC, says Piper Sandler 04/28/20 Piper Sandler Untreated heart attacks negative for Abiomed, says Piper Sandler 04/22/20 SVB Leerink Boston Scientific downgraded to Market Perform at SVB Leerink on slower recovery 04/22/20 SVB Leerink Boston Scientific downgraded to Market Perform from Outperform at SVB Leerink SIG Signet Jewelers $10.20 / +0.04 (+0.39%) 03/27/20 BofA Signet Jewelers downgraded to Underperform from Neutral at BofA 03/27/20 BofA Signet Jewelers downgraded to Underperform from Neutral at BofA 01/17/20 Citi Signet Jewelers price target raised to $22 from $13 at Citi 01/02/20 Fly Intel: Top five analyst downgrades A Agilent $87.10 / +6.26 (+7.74%) 05/22/20 Cowen Agilent price target raised to $95 from $80 at Cowen 03/30/20 Wells Fargo Agilent price target lowered to $82 from $100 at Wells Fargo 02/24/20 Needham Agilent downgraded to Hold from Buy at Needham 02/24/20 Needham Agilent downgraded to Hold from Buy at Needham SIG NVDA NEM BSX A SIG Signet Jewelers $10.20 / +0.04 (+0.39%) 03/26/20 Signet Jewelers reports Q4 adjusted EPS $3.67, consensus $3.47 03/23/20 Signet Jewelers not providing Q1 or FY21 guidance 03/23/20 Signet Jewelers not providing FY21 guidance 01/16/20 Signet Jewelers raises FY20 adj. EPS view to $3.61-$3.69, consensus $3.26 NVDA Nvidia $350.67 / -0.34 (-0.10%) 05/21/20 Nvidia sees Q2 revenue $3.65B +/- 2%, consensus $3.15B 05/21/20 Nvidia reports Q1 EPS $1.80, consensus $1.68 05/21/20 Notable companies reporting after market close 02/13/20 Nvidia says Mellanox acquisition likely to close in early calendar 2020 NEM Newmont $63.90 / +0.37 (+0.58%) 05/05/20 Newmont reports Q1 adjusted EPS 40c, consensus 42c 02/20/20 Newmont reports Q4 adjusted EPS 50c, consensus 47c BSX Boston Scientific $35.53 / +0.72 (+2.07%) 04/29/20 Boston Scientific unable to estimate overall impacts on FY20 financial results 04/29/20 Boston Scientific reports Q1 adj. EPS 28c, consensus 31c 04/28/20 Notable companies reporting before tomorrow's open A Agilent $87.10 / +6.26 (+7.74%) 05/21/20 Agilent reports Q2 adjusted EPS 71c, consensus 61c 02/18/20 Agilent backs FY20 adjusted EPS view $3.38-$3.43, consensus $3.42 02/18/20 Agilent sees Q2 adjusted EPS 72c-76c, consensus 79c 02/18/20 Agilent reports Q1 adjusted EPS 81c, consensus 81c 22 May NVDA NEM BSX A NVDA Nvidia $350.67 / -0.34 (-0.10%) 05/22/20 Samsung starts construction on 5nm fab facility, Bloomberg reports 05/13/20 FalconX raises $17M to support its crypto trading service, TechCrunch says 05/05/20 TSMC receives orders for Nvidia's 7nm, 5nm GPU, DigiTimes reports 04/24/20 Nvidia's reportedly ordering 5nm chips for a 'mystery' product, TechRadar says NEM Newmont $63.90 / +0.37 (+0.58%) 04/17/20 Newmont aims to reopen some Canadian and South American mines, Reuters says BSX Boston Scientific $35.53 / +0.72 (+2.07%) 12/18/19 Boston Scientific ordered to complete Channel Medsystems deal, Bloomberg reports 12/18/19 Boston Scientific ordered to complete Channel Medsystems deal, Bloomberg reports A Agilent $87.10 / +6.26 (+7.74%) 02/08/20 Sustainable companies in America beating the market, Barron's says SIG NVDA BSX A SIG Signet Jewelers $10.20 / +0.04 (+0.39%) 03/26/20 Fly Intel: Wall Street's top stories for Thursday 03/26/20 Fly Intel: Wall Street's top stories at midday 03/26/20 Fly Intel: Pre-market Movers 03/23/20 Fly Intel: Wall Street's top stories for Monday NVDA Nvidia $350.67 / -0.34 (-0.10%) 05/22/20 Fly Intel: HP Enterprise, Roku downgrades among today's top calls on Wall Street 05/22/20 The Intersection: Crypto and Wall Street This Week 05/22/20 Fly Intel: Pre-market Movers 05/21/20 Fly Intel: After-Hours Movers BSX Boston Scientific $35.53 / +0.72 (+2.07%) 05/21/20 Fly Intel: Pre-market Movers 05/20/20 Fly Intel: After-Hours Movers A Agilent $87.10 / +6.26 (+7.74%) 02/24/20 Plethora of downgrades among today's top analyst calls 06/01/20 2020 Cloud Secular Winners Virtual Conference 06/08/20 Virtual Software & Semiconductor Bus Tour 06/12/20 FBN Silicon Valley Tech Virtual Tour 06/15/20 42nd Nasdaq Investor Conference 09/14/20 ShopTalk 2020 06/09/20 Signet Jewelers - SIG 06/09/20 NVIDIA Corp. 06/12/20 Signet Jewelers Ltd. SIG NVDA NEM BSX A SIG Signet Jewelers $10.20 / +0.04 (+0.39%) 05/08/20 Signet Jewelers call volume above normal and directionally bullish 04/29/20 Early notable gainers among liquid option names on April 29th 04/22/20 Signet Jewelers put volume heavy and directionally bearish 04/17/20 Early notable gainers among liquid option names on April 17th NVDA Nvidia $350.67 / -0.34 (-0.10%) 05/22/20 Notable open interest changes for May 22nd 05/21/20 NVIDIA options imply 8.7% move in share price post-earnings 05/13/20 Early notable gainers among liquid option names on May 13th NEM Newmont $63.90 / +0.37 (+0.58%) 05/19/20 Early notable gainers among liquid option names on May 19th 05/14/20 Early notable gainers among liquid option names on May 14th 04/09/20 Newmont Mining call volume above normal and directionally bullish 04/06/20 Newmont Mining call volume above normal and directionally bullish BSX Boston Scientific $35.53 / +0.72 (+2.07%) 04/21/20 Boston Scientific call volume above normal and directionally bullish 03/24/20 Boston Scientific call volume above normal and directionally bullish 01/14/20 Boston Scientific put volume heavy and directionally bearish A Agilent $87.10 / +6.26 (+7.74%) 02/20/20 Agilent put volume heavy and directionally bearish 12/30/19 Agilent call volume above normal and directionally bullish 11/27/19 Largest borrow rate increases among liquid names
Recommendations	Agilent price target raised to $95 from $80 at Cowen » 07:48 05/22/20 05/22 07:48 05/22/20 07:48 A Agilent $80.84 / -0.83 (-1.02%) Cowen analyst Doug… Cowen analyst Doug Schenkel raised the firm's price target on Agilent to $95 from $80 and keeps an Outperform rating on the shares. The analyst said the company posted a strong top and bottom beat, aided by resilient pharma trends and a significant bounce in China. Schenkel said the long-term outlook remains exciting. ShowHide Related Items >><< Company News Street Research Earnings Periodicals On The Fly Options A Agilent $80.84 / -0.83 (-1.02%) 05/21/20 Agilent up 5% to $84.70 after Q2 results beat estimates 05/18/20 Agilent PD-L1 assay receives FDA approval for use as companion diagnostic 05/15/20 Ackman's Pershing Square adds Blackstone, cuts Chipotle in Q1 05/15/20 FDA approves Agilent PD-L1 diagnostic device for lung cancer A Agilent $80.84 / -0.83 (-1.02%) 03/30/20 Wells Fargo Agilent price target lowered to $82 from $100 at Wells Fargo 02/24/20 Needham Agilent downgraded to Hold from Buy at Needham 02/24/20 Needham Agilent downgraded to Hold from Buy at Needham 02/19/20 Piper Sandler Agilent price target raised to $96 from $86 at Piper Sandler A Agilent $80.84 / -0.83 (-1.02%) 05/21/20 Agilent reports Q2 adjusted EPS 71c, consensus 61c 02/18/20 Agilent backs FY20 adjusted EPS view $3.38-$3.43, consensus $3.42 02/18/20 Agilent sees Q2 adjusted EPS 72c-76c, consensus 79c 02/18/20 Agilent reports Q1 adjusted EPS 81c, consensus 81c A Agilent $80.84 / -0.83 (-1.02%) 02/08/20 Sustainable companies in America beating the market, Barron's says A Agilent $80.84 / -0.83 (-1.02%) 05/21/20 Fly Intel: After-Hours Movers 02/24/20 Plethora of downgrades among today's top analyst calls A Agilent $80.84 / -0.83 (-1.02%) 02/20/20 Agilent put volume heavy and directionally bearish 12/30/19 Agilent call volume above normal and directionally bullish 11/27/19 Largest borrow rate increases among liquid names
On The Fly	Fly Intel: After-Hours Movers » 19:01 05/21/20 05/21 19:01 05/21/20 19:01 PANW Palo Alto Networks $229.36 / -4.89 (-2.09%) , RAMP LiveRamp $38.70 / -0.16 (-0.41%) , CRMT America's Car-Mart $73.77 / +2.825 (+3.98%) , ELF e.l.f. Beauty $14.56 / +0.34 (+2.39%) , A Agilent $80.84 / -0.83 (-1.02%) , SPLK Splunk $163.27 / +0.11 (+0.07%) , DECK Deckers Brands $167.93 / +5.83 (+3.60%) , PRSP Perspecta $22.93 / -0.4 (-1.71%) , PLUS ePlus $76.14 / +4.14 (+5.75%) , NAVB Navidea $1.32 / +0.06 (+4.76%) , USFD US Foods $18.56 / -0.24 (-1.28%) , NYMT New York Mortgage $2.04 / +0.105 (+5.43%) , AGYS Agilysys $20.11 / +0.79 (+4.09%) , HPE HP Enterprise $10.35 / +0.07 (+0.68%) , LGF.A Lionsgate $8.61 / +0.13 (+1.53%) , ROST Ross Stores $97.01 / +6.1 (+6.71%) , INTU Intuit $290.30 / -0.4 (-0.14%) , CHUY Chuy's $16.13 / +0.09 (+0.56%) , NVDA Nvidia $351.01 / -7.78 (-2.17%) , SNDX Syndax $20.51 / +0.34 (+1.69%) , GERN Geron $1.95 / +0.06 (+3.17%) , CFRX ContraFect $5.38 / -0.22 (-3.93%) , DSS Document Security $8.50 / +0.22 (+2.66%) , H Hyatt $53.45 / -0.49 (-0.91%) Check out this evening's… Open Full Text ShowHide Related Items >><< Company News Street Research Earnings Syndicate Periodicals On The Fly Events Options USFD SPLK SNDX ROST RAMP PRSP PLUS PANW NYMT NVDA NAVB LGF.A INTU HPE H GERN ELF DSS DECK CRMT CHUY CFRX AGYS A USFD US Foods $18.56 / -0.24 (-1.28%) 05/21/20 US Foods jumps after KKR reveals active stake, may seek talks 05/21/20 KKR reports active stake in US Foods 05/05/20 US Foods reports Q1 total case volume up 3.4% 04/21/20 US Foods awarded maximum $478.02M Defense Logistics Agency contract SPLK Splunk $163.27 / +0.11 (+0.07%) 05/05/20 Google Cloud and Splunk announce partnership 03/24/20 Quantum Computing announces technology partnership with Splunk 03/06/20 Splunk CEO: We are growing our cloud business like crazy 03/04/20 Fly Intel: After Hours Movers SNDX Syndax $20.51 / +0.34 (+1.69%) 05/21/20 Syndax plunges 19.5% after E2112 Phase 3 trial fails to meet primary endpoint 05/21/20 Syndax trading resumes 05/21/20 Syndax says E2112 Phase 3 trial did not achieve primary endpoint 05/21/20 Syndax trading halted, news pending ROST Ross Stores $97.01 / +6.1 (+6.71%) 05/21/20 Ross Stores slips 2.6% after Q1 results 04/02/20 Ross Stores to furlough majority of associates, stores to remain closed 03/20/20 Ross Stores temporarily closes all stores due to COVID-19 developments 03/19/20 Ross Stores issues COVID-19 update, withdraws Q1, FY20 guidance RAMP LiveRamp $38.70 / -0.16 (-0.41%) 03/12/20 LiveRamp Holdings trading resumes 03/12/20 LiveRamp Holdings trading halted, volatility trading pause 02/05/20 Fly Intel: After Hours Movers 01/28/20 LiveRamp, TripleLift partners to bring addressability to open web PRSP Perspecta $22.93 / -0.4 (-1.71%) 05/14/20 Perspecta awarded $237.24M ceiling Army contract for training, education info 04/29/20 Perspecta and Oasys JV wins prime position on $13.4B Air Force IT program 04/22/20 Perspecta wins $14.5M award for defensive cyber operations 04/07/20 Perspecta wins $36.4M follow-on task order PLUS ePlus $76.14 / +4.14 (+5.75%) 05/21/20 ePlus says well positioned in the marketplace 05/20/20 ePlus announces 500,000 share stock repurchase plan 02/05/20 ePlus sees FY20 as 'year of significant growth' PANW Palo Alto Networks $229.36 / -4.89 (-2.09%) 05/21/20 Palo Alto Networks CEO: COVID-19 accelerated Cloud transformation 05/21/20 Palo Alto Networks up 7% to $245.50 after Q3 results beat estimates 05/21/20 Palo Alto Networks reports Q3 billings up 24% y/y to $1B 05/21/20 Palo Alto Networks sees FY20 total billings $4.102B-$4.122B NYMT New York Mortgage $2.04 / +0.105 (+5.43%) 04/07/20 New York Mortgage 'made significant progress in strengthening liquidity' 03/30/20 New York Mortgage says 'exploring additional financing options' 01/08/20 Fly Intel: Pre-market Movers NVDA Nvidia $351.01 / -7.78 (-2.17%) 05/21/20 Nvidia CEO says Cloud computing journey has long way to go 05/21/20 Nvidia down 1% at $347.50 per share after Q1 earnings 05/21/20 Nvidia reports Q1 Gaming revenue up 27% from last year at $1.34B 05/21/20 Nvidia sees Q2 gross margin 65.5%-66.5% NAVB Navidea $1.32 / +0.06 (+4.76%) 05/21/20 Navidea surges nearly 30% after 'positive' arthritis study results 05/21/20 Navidea reports 'positive' preliminary results from ongoing Phase 2B RA study 05/11/20 Navidea regains commercialization, distribution rights in EU for LYMPHOSEEK 04/22/20 Navidea issues statement, clinical trial update amid COVID-19 pandemic LGF.A Lionsgate $8.61 / +0.13 (+1.53%) 05/21/20 Lionsgate 'may not be able to accurately predict' impact of COVID-19 05/21/20 Lionsgate reports Q4 adjusted OIBDA of $126M 04/21/20 Lionsgate to adapt Suzanne Collins's new Hunger Games novel 04/14/20 Lionsgate renews long-term partnership with Grindstone Entertainment Group INTU Intuit $290.30 / -0.4 (-0.14%) 05/21/20 Intuit reports Q3 Consumer Group revenue down 15%, Small Business up 11% 05/21/20 Intuit CEO says IRS filing season delay, shelter-in-place impacted quarter 04/12/20 Intuit QuickBooks Capital approved as Paycheck Protection Program lender 04/05/20 Intuit launches free Stimulus Registration product HPE HP Enterprise $10.35 / +0.07 (+0.68%) 05/20/20 Phunware partners with HP Enterprise on mobile healthcare solution 05/11/20 Aruba enters collaboration with Microsoft 04/20/20 HP Enterprise announces 12c per share quarterly dividend 04/14/20 AMD extends 2nd Gen AMD EPYC processor family with new processors H Hyatt $53.45 / -0.49 (-0.91%) 05/12/20 Hyatt to lay off 1,300 employees, restructure roles 05/06/20 Hyatt says liquidity adequate to fund operations for at least 30 months 05/06/20 Hyatt says occupancy in Greater China has shown gradual improvement 05/04/20 Choice Hotels announces 'Commitment to Clean' initiative GERN Geron $1.95 / +0.06 (+3.17%) 05/21/20 Geron provides update on ongoing Phase 3 IMerge trial 05/21/20 Geron announces plans for Phase 3 imetelstat trial in MF patients 04/02/20 Geron expects 2020 operating expense burn to be lower than $70M-$75M 04/02/20 Geron expects to announce decision regarding MF development plans by mid-year ELF e.l.f. Beauty $14.56 / +0.34 (+2.39%) 05/21/20 e.l.f. Beauty suspends FY21 guidance 05/21/20 e.l.f. Beauty accessed $20M of revolving credit facility 05/21/20 e.l.f. Beauty says China based suppliers fully operational 05/04/20 Marathon Partners reports 5.2% active stake in e.l.f. Beauty DSS Document Security $8.50 / +0.22 (+2.66%) 05/04/20 DSS enters share exchange agreement, acquisition of Impact Biomedical 04/27/20 Document Security to proceed with Impact BioMedical acquisition after valuation 03/16/20 Document Security enters proposed JV over U.S.-based medical REIT 03/12/20 Document Security enters into LOI to acquire Impact Biomedical DECK Deckers Brands $167.93 / +5.83 (+3.60%) 03/24/20 Deckers Brands resumes operations with limited capacity at Moreno Valley center 03/20/20 Deckers Brands to temporarily close Moreno Valley distribution center 03/17/20 Deckers Brands says UGG stores in North America, Europe temporarily closing 01/30/20 Deckers Brands sees FY20 gross margin approximately 51.5% CRMT America's Car-Mart $73.77 / +2.825 (+3.98%) 02/19/20 Fly Intel: After Hours Movers 02/13/20 America's Car-Mart to replace Care.com in S&P 600 at open on 2/13 12/17/19 America's Car-Mart acquires Illinois dealerships, terms not disclosed CHUY Chuy's $16.13 / +0.09 (+0.56%) 05/21/20 Chuy's suspends further share repurchases for remainder of year 05/08/20 Chuy's files to delay 10-Q 04/21/20 Chuy's in negotiations to extend revolving credit facility 04/21/20 Chuy's sees approx. $3M in tax refunds due to the CARES Act CFRX ContraFect $5.38 / -0.22 (-3.93%) 05/15/20 ContraFect experiences delays in patient enrollment for Phase 3 DISRUPT study 05/11/20 ContraFect announces four abstracts published in 30th ECCMID abstract book 02/24/20 ContraFect receives Breakthrough Therapy designation for Exebacase 02/04/20 ContraFect announces 1-for-10 reverse stock split AGYS Agilysys $20.11 / +0.79 (+4.09%) 04/08/20 Agilysys says will miss Q4 revenue guidance A Agilent $80.84 / -0.83 (-1.02%) 05/21/20 Agilent up 5% to $84.70 after Q2 results beat estimates 05/18/20 Agilent PD-L1 assay receives FDA approval for use as companion diagnostic 05/15/20 Ackman's Pershing Square adds Blackstone, cuts Chipotle in Q1 05/15/20 FDA approves Agilent PD-L1 diagnostic device for lung cancer PANW RAMP CRMT ELF A SPLK DECK PRSP PLUS NAVB USFD NYMT AGYS HPE LGF.A ROST INTU CHUY NVDA SNDX GERN CFRX DSS H PANW Palo Alto Networks $229.36 / -4.89 (-2.09%) 05/20/20 Wells Fargo Palo Alto Networks price target raised to $250 from $225 at Wells Fargo 05/20/20 Monness Crespi Palo Alto Networks price target raised to $255 from $210 at Monness Crespi 05/19/20 Dougherty Dougherty sees Palo Alto set up for rebound, upgrades to Buy 05/19/20 Dougherty Palo Alto Networks upgraded to Buy from Neutral at Dougherty RAMP LiveRamp $38.70 / -0.16 (-0.41%) 04/27/20 Needham LiveRamp price target lowered to $57 from $70 at Needham 04/21/20 Berenberg LiveRamp initiated with a Buy at Berenberg 03/13/20 Stephens LiveRamp weakness creates 'real opportunity,' says Stephens 01/26/20 First Analysis First Analysis sees continued top-line momentum in 2020 for LiveRamp CRMT America's Car-Mart $73.77 / +2.825 (+3.98%) 03/27/20 Stephens America's Car-Mart upgraded to Overweight from Equal Weight at Stephens 02/13/20 Janney Montgomery Scott America's Car-Mart downgraded to Neutral from Buy at Janney Montgomery Scott ELF e.l.f. Beauty $14.56 / +0.34 (+2.39%) 04/08/20 Piper Sandler Piper lays out winners and losers in survey of 5,200 teens 03/18/20 DA Davidson e.l.f. Beauty price target lowered to $12 from $24.50 at DA Davidson 02/06/20 Piper Sandler e.l.f. Beauty price target raised to $23 from $19 at Piper Sandler 02/04/20 Fly Intel: Top five analyst upgrades A Agilent $80.84 / -0.83 (-1.02%) 03/30/20 Wells Fargo Agilent price target lowered to $82 from $100 at Wells Fargo 02/24/20 Needham Agilent downgraded to Hold from Buy at Needham 02/24/20 Needham Agilent downgraded to Hold from Buy at Needham 02/19/20 Piper Sandler Agilent price target raised to $96 from $86 at Piper Sandler SPLK Splunk $163.27 / +0.11 (+0.07%) 05/14/20 Cleveland Research Splunk estimates at risk amid enterprise weakness, says Cleveland Research 04/27/20 Needham Splunk price target lowered to $168 from $181 at Needham 04/24/20 Cowen Splunk downgraded to Market Perform at Cowen 04/24/20 Cowen Splunk downgraded to Market Perform from Outperform at Cowen DECK Deckers Brands $167.93 / +5.83 (+3.60%) 05/18/20 Wedbush Deckers Brands price target raised to $155 from $145 at Wedbush 05/15/20 Pivotal Research Deckers Brands price target lowered to $165 from $217 at Pivotal Research 05/14/20 Wells Fargo Wells Fargo downgrades Steven Madden to Underweight on brand weakness 04/28/20 BTIG Deckers Brands initiated with a Buy at BTIG PRSP Perspecta $22.93 / -0.4 (-1.71%) 04/02/20 Wells Fargo Perspecta price target lowered to $18.50 from $26 at Wells Fargo 03/30/20 William Blair Perspecta initiated with a Market Perform at William Blair 03/25/20 Wells Fargo Good news for government contractors in COVID -19 bill, says Wells Fargo 02/25/20 Morgan Stanley Morgan Stanley upgrades Perspecta to Equal Weight on overhang removal PLUS ePlus $76.14 / +4.14 (+5.75%) 02/11/20 Berenberg ePlus upgraded to Buy from Hold at Berenberg 02/06/20 Sidoti ePlus upgraded to Buy after earnings at Sidoti 02/06/20 Sidoti ePlus upgraded to Buy from Neutral at Sidoti 11/14/19 Sidoti ePlus downgraded to Neutral from Buy at Sidoti NAVB Navidea $1.32 / +0.06 (+4.76%) 11/22/19 H.C. Wainwright Navidea initiated with a Buy at H.C. Wainwright 07/11/19 Fly Intel: Top five analyst initiations 07/11/19 Maxim Navidea initiated with a Buy at Maxim 07/11/19 Maxim Navidea initiated with a Buy at Maxim USFD US Foods $18.56 / -0.24 (-1.28%) 05/18/20 Guggenheim US Foods price target lowered to $30 from $50 at Guggenheim 04/27/20 Credit Suisse US Foods price target lowered to $27 from $47 at Credit Suisse 04/23/20 BMO Capital US Foods downgraded to Market Perform from Outperform at BMO Capital 04/06/20 JPMorgan US Foods price target lowered to $24 from $45 at JPMorgan NYMT New York Mortgage $2.04 / +0.105 (+5.43%) 04/24/20 Credit Suisse New York Mortgage upgraded to Neutral from Underperform at Credit Suisse 04/24/20 Credit Suisse New York Mortgage upgraded to Neutral from Underperform at Credit Suisse 03/25/20 Maxim AGNC Investment, New York Mortgage Trust cut to Hold at Maxim 03/25/20 Maxim New York Mortgage downgraded to Hold from Buy at Maxim AGYS Agilysys $20.11 / +0.79 (+4.09%) 04/16/20 BTIG Agilysys initiated with a Neutral at BTIG 03/16/20 Craig-Hallum Agilysys price target lowered to $27 from $40 at Craig-Hallum 01/29/20 Craig-Hallum Agilysys price target raised to $40 from $32 at Craig-Hallum 12/03/19 Craig-Hallum Agilysys initiated with a Buy at Craig-Hallum HPE HP Enterprise $10.35 / +0.07 (+0.68%) 05/19/20 Barclays Barclays lowers estimates in IT hardware after April survey 04/27/20 Loop Capital Xerox, Park City, NetApp, HP Enterprise cut to Hold from Buy at Loop Capital 04/27/20 Loop Capital HP Enterprise downgraded to Hold from Buy at Loop Capital 04/22/20 Fly Intel: Top five analyst initiations LGF.A Lionsgate $8.61 / +0.13 (+1.53%) 04/27/20 RBC Capital Lionsgate initiated with a Sector Perform at RBC Capital 04/22/20 Deutsche Bank Lionsgate price target lowered to $10 from $22 at Deutsche Bank 04/21/20 JPMorgan Lionsgate price target lowered to $11 from $14 at JPMorgan 03/23/20 Lionsgate participates in a conference call with SunTrust ROST Ross Stores $97.01 / +6.1 (+6.71%) 05/19/20 Jefferies TJX to benefit from 'biggest liquidation sale in history,' says Jefferies 05/11/20 Nomura Instinet Ross Stores price target raised to $100 from $80 at Nomura Instinet 04/28/20 DA Davidson Ross Stores upgraded to Buy from Neutral at DA Davidson 04/28/20 DA Davidson Ross Stores upgraded to Buy from Neutral at DA Davidson INTU Intuit $290.30 / -0.4 (-0.14%) 05/19/20 KeyBanc Intuit price target raised to $315 from $285 at KeyBanc 05/05/20 KeyBanc Intuit price target raised to $285 from $275 at KeyBanc 04/17/20 RBC Capital Intuit lowered to $280 from $345 at RBC Capital 04/13/20 Jefferies Jefferies continues to like Intuit after approval for small business lending CHUY Chuy's $16.13 / +0.09 (+0.56%) 04/23/20 BMO Capital Chuy's upgraded to Market Perform from Underperform at BMO Capital 04/20/20 Raymond James Chuy's price target raised to $17 from $14 at Raymond James 04/08/20 Wedbush Chuy's price target lowered to $17 from $26 at Wedbush 04/02/20 Raymond James Chuy's upgraded to Outperform from Market Perform at Raymond James NVDA Nvidia $351.01 / -7.78 (-2.17%) 05/21/20 Credit Suisse Nvidia reinstated with an Outperform at Credit Suisse 05/19/20 RBC Capital Nvidia price target raised to $385 from $350 at RBC Capital 05/19/20 Susquehanna Nvidia price target raised to $410 from $355 at Susquehanna 05/18/20 Fly Intel: Top five analyst upgrades SNDX Syndax $20.51 / +0.34 (+1.69%) 05/18/20 Citi Syndax downgraded to Neutral from Buy at Citi 05/11/20 H.C. Wainwright Syndax price target raised to $25 from $19 at H.C. Wainwright 05/08/20 Nomura Instinet Syndax price target raised to $31 from $16 at Nomura Instinet 05/04/20 Baird Syndax risk/reward solid following positive clinical data, says Baird GERN Geron $1.95 / +0.06 (+3.17%) 11/19/19 B. Riley FBR B. Riley FBR resumes Geron with Buy rating, $4 price target 11/19/19 B. Riley FBR Geron resumed with a Buy at B. Riley FBR 09/03/19 H.C. Wainwright Geron initiated with a Buy at H.C. Wainwright 08/15/19 Cantor Fitzgerald Geron initiated with an Overweight at Cantor Fitzgerald CFRX ContraFect $5.38 / -0.22 (-3.93%) 10/02/19 Piper Sandler Piper says design differentiates ContraFect trial from other antibiotic studies 06/11/19 Maxim ContraFect initiated with a Buy at Maxim DSS Document Security $8.50 / +0.22 (+2.66%) 10/10/19 Aegis Document Security initiated with a Buy rating at Aegis H Hyatt $53.45 / -0.49 (-0.91%) 05/08/20 Fly Intel: Top five analyst downgrades 05/08/20 Deutsche Bank Hyatt price target lowered to $54 from $86 at Deutsche Bank 05/08/20 Macquarie Hyatt downgraded to Neutral from Outperform at Macquarie 04/22/20 BofA Choice Hotels upgraded to Neutral from Underperform at Bofa USFD SPLK SNDX ROST RAMP PRSP PLUS PANW NYMT NVDA LGF.A INTU HPE H GERN ELF DSS DECK CRMT CHUY CFRX AGYS A USFD US Foods $18.56 / -0.24 (-1.28%) 05/05/20 US Foods not providing new fiscal 2020 financial guidance 05/05/20 US Foods reports Q1 adjusted EPS 15c, consensus 28c 05/04/20 Notable companies reporting before tomorrow's open SPLK Splunk $163.27 / +0.11 (+0.07%) 05/21/20 Splunk sees Q2 revenue $520M, consensus $550.57M 05/21/20 Splunk reports Q1 adjusted EPS (56c), consensus (57c) 03/04/20 Splunk sees FY21 revenue $2.6B, consensus $2.88B SNDX Syndax $20.51 / +0.34 (+1.69%) 05/07/20 Syndax reports Q1 EPS (56c), consensus (51c) 03/03/20 Syndax reports Q4 EPS (44c), consensus (42c) ROST Ross Stores $97.01 / +6.1 (+6.71%) 05/21/20 Ross Stores not providing Q2, FY20 guidance 05/21/20 Ross Stores reports Q1 EPS (87c), consensus 6c 03/03/20 Ross Stores sees FY21 EPS $4.67-$4.88, consensus $5.01 RAMP LiveRamp $38.70 / -0.16 (-0.41%) 05/21/20 LiveRamp sees Q1 revenue roughly $88M, consensus $101.14M 05/21/20 LiveRamp reports Q4 adjusted EPS (5c), consensus (14c) 02/05/20 LiveRamp backs FY20 revenue view $376M-$381M, consensus $377.54M 02/05/20 LiveRamp reports Q3 adjusted EPS (3c), consensus (9c) PRSP Perspecta $22.93 / -0.4 (-1.71%) 05/21/20 Perspecta sees FY21 adjusted EPS $1.90-$2.03, consensus $1.96 05/21/20 Perspecta reports Q4 adjusted EPS 55c, consensus 51c 02/12/20 Perspecta raises FY20 adj. EPS view to $2.12-$2.18 from $2.10-$2.18 02/12/20 Perspecta reports Q3 adjusted EPS 55c, consensus 53c PLUS ePlus $76.14 / +4.14 (+5.75%) 05/21/20 ePlus reports Q4 adj. EPS $1.24, consensus 95c 02/05/20 ePlus reports Q3 EPS $1.64, consensus $1.36 PANW Palo Alto Networks $229.36 / -4.89 (-2.09%) 05/21/20 Palo Alto Networks sees FY20 adjusted EPS $4.78-$4.81, consensus $4.48 05/21/20 Palo Alto Networks sees Q4 adjusted EPS $1.37-$1.40, consensus $1.30 05/21/20 Palo Alto Networks reports Q3 adjusted EPS $1.17, consensus 93c 05/21/20 Notable companies reporting after market close NYMT New York Mortgage $2.04 / +0.105 (+5.43%) 05/21/20 New York Mortgage reports Q1 EPS ($1.71), consensus 13c 02/24/20 New York Mortgage reports Q4 EPS 20c, consensus 17c 02/10/20 New York Mortgage reports preliminary Q4 EPS 19c-21c, consensus 17c NVDA Nvidia $351.01 / -7.78 (-2.17%) 05/21/20 Nvidia sees Q2 revenue $3.65B +/- 2%, consensus $3.15B 05/21/20 Nvidia reports Q1 EPS $1.80, consensus $1.68 02/13/20 Nvidia says Mellanox acquisition likely to close in early calendar 2020 LGF.A Lionsgate $8.61 / +0.13 (+1.53%) 05/21/20 Lionsgate reports Q4 adjusted EPS 21c, consensus (6c) 02/06/20 Lionsgate reports Q3 adjusted EPS 14c, consensus (13c) 02/06/20 Notable companies reporting after market close INTU Intuit $290.30 / -0.4 (-0.14%) 05/21/20 Intuit reports Q3 EPS $4.49, consensus $5.48 05/07/20 Intuit cuts Q3 EPS view to $4.46-$4.49 from $5.90-$5.95, consensus $5.48 05/06/20 Fly Intel: What to watch in PayPal earnings report HPE HP Enterprise $10.35 / +0.07 (+0.68%) 05/21/20 HP Enterprise sees cash funding payments of $1B-$1.3B over next 3 years 05/21/20 HP Enterprise not providing Q3 or FY20 guidance 05/21/20 HP Enterprise reports Q2 adjusted EPS 22c, consensus 30c H Hyatt $53.45 / -0.49 (-0.91%) 05/06/20 Hyatt reports Q1 adjusted EPS (35c), consensus (14c) 04/21/20 Hyatt sees Q1 revenue $980M-$1B, consensus $1.05B 03/02/20 Hyatt withdraws FY20 outlook due to evolving coronavirus impact 02/19/20 Hyatt sees FY20 adj. EBITDA $760M-$780M, RevPAR growth down 0.5% to up 1.5% GERN Geron $1.95 / +0.06 (+3.17%) 03/12/20 Geron reports Q4 EPS (15c), consensus (20c) ELF e.l.f. Beauty $14.56 / +0.34 (+2.39%) 05/21/20 e.l.f. Beauty reports Q4 adj. EPS 10c, consensus 5c 03/30/20 e.l.f. Beauty reaffirms FY20 guidance issued on February 5 02/05/20 e.l.f. Beauty boosts FY20 adjusted EPS view to 55c-59c from 44c-48c DSS Document Security $8.50 / +0.22 (+2.66%) 04/06/20 Document Security reports FY19 EPS (11c), two est. (13c) DECK Deckers Brands $167.93 / +5.83 (+3.60%) 05/21/20 Deckers Brands reports Q4 EPS 57c, consensus 21c 01/30/20 Deckers Brands raises FY20 EPS view to $9.40-$9.50 from $8.90-$9.05 01/30/20 Deckers Brands reports Q3 EPS $7.14, consensus $6.55 CRMT America's Car-Mart $73.77 / +2.825 (+3.98%) 05/21/20 America's Car-Mart reports Q1 EPS $1.35, consensus $1.51 02/19/20 America's Car-Mart reports Q3 EPS $1.83, consensus $1.77 CHUY Chuy's $16.13 / +0.09 (+0.56%) 05/21/20 Chuy's withdraws FY20 guidance 05/21/20 Chuy's Holdings reports Q1 adjusted EPS 1c, consensus 7c 03/30/20 Chuy's withdraws 2020 financial guidance 03/05/20 Chuy's sees FY20 EPS $1.15-$1.19, consensus $1.10 CFRX ContraFect $5.38 / -0.22 (-3.93%) 05/15/20 ContraFect reports Q1 EPS (49c), consensus (62c) 03/18/20 ContraFect reports Q4 EPS ($1.11), consensus (83c) AGYS Agilysys $20.11 / +0.79 (+4.09%) 05/21/20 Agilysys sees Q1 revenue to decrease by as much as 35% y/y 05/21/20 Agilysys reports Q4 adjusted EPS 5c, consensus (5c 01/29/20 Agilysys raises forecast for FY20 revenue growth to 16% from 14% 01/28/20 Agilysys reports Q3 EPS (11c), consensus (7c) A Agilent $80.84 / -0.83 (-1.02%) 05/21/20 Agilent reports Q2 adjusted EPS 71c, consensus 61c 02/18/20 Agilent backs FY20 adjusted EPS view $3.38-$3.43, consensus $3.42 02/18/20 Agilent sees Q2 adjusted EPS 72c-76c, consensus 79c 02/18/20 Agilent reports Q1 adjusted EPS 81c, consensus 81c 22 May 22 May 22 May ROST PANW NVDA LGF.A INTU HPE H A ROST Ross Stores $97.01 / +6.1 (+6.71%) 03/26/20 Ross Stores cancels merchandise purchase orders through June 18, Reuters says 03/26/20 Ross Stores cancels merchandise purchase orders through June 18, Reuters says PANW Palo Alto Networks $229.36 / -4.89 (-2.09%) 05/13/20 Pixel executives have left Google amid division 'shakeup,' The Information says 03/16/20 HHS suffers cyber-attack amid COVID-19 outbreak, Bloomberg reports 02/20/20 DISA suffered breach of secure communications network, Reuters reports NVDA Nvidia $351.01 / -7.78 (-2.17%) 05/13/20 FalconX raises $17M to support its crypto trading service, TechCrunch says 05/05/20 TSMC receives orders for Nvidia's 7nm, 5nm GPU, DigiTimes reports 04/24/20 Nvidia's reportedly ordering 5nm chips for a 'mystery' product, TechRadar says 04/23/20 TSMC seeing ramp-up in orders from AMD, Nvidia, DigiTimes reports LGF.A Lionsgate $8.61 / +0.13 (+1.53%) 02/13/20 Delrahim could soon file criminal antitrust case in Silicon Valley, THR reports 12/09/19 Netflix leads Golden Globe noms with 34, WSJ reports INTU Intuit $290.30 / -0.4 (-0.14%) 04/14/20 PayPal, Square, Intuit begin lending to small businesses, Bloomberg reports 03/11/20 Trump administration may extend April 15th tax filing deadline, WSJ says 03/09/20 Intuit 'looking hard' at buying Finicity or another fintech, Barron's says 02/23/20 Intuit near deal to buy Credit Karma for $7B in cash and stock, WSJ reports HPE HP Enterprise $10.35 / +0.07 (+0.68%) 12/30/19 Chinese 'Cloud Hopper' attack much bigger than previously known, WSJ says 11/30/19 Legacy technology companies in awkward spot, Barron's says 11/23/19 Barron's recommends fourteen value stocks H Hyatt $53.45 / -0.49 (-0.91%) 03/31/20 Hyatt execs who took pay cut could gain through stock awards, WSJ reports 03/22/20 Marriott furloughing thousands of corporate employees, WSJ reports 03/18/20 NYC may turn hotels into hospitals for non-Covid patients, WSJ says 03/18/20 Hotel industry asks Trump administration for $150B bailout, WSJ reports A Agilent $80.84 / -0.83 (-1.02%) 02/08/20 Sustainable companies in America beating the market, Barron's says USFD SPLK SNDX RAMP PRSP PANW NYMT NVDA LGF.A INTU HPE H ELF DECK CHUY A USFD US Foods $18.56 / -0.24 (-1.28%) 05/05/20 Fly Intel: Pre-market Movers SPLK Splunk $163.27 / +0.11 (+0.07%) 04/24/20 Fly Intel: Pre-market Movers 03/05/20 Fly Intel: FireEye upgrade, J&J initiation among today's Wall Street top calls 11/22/19 Fly Intel: Wall Street's top stories for Friday SNDX Syndax $20.51 / +0.34 (+1.69%) 04/28/20 Fly Intel: Wall Street's top stories for Tuesday 04/28/20 Fly Intel: Wall Street's top stories at midday RAMP LiveRamp $38.70 / -0.16 (-0.41%) 01/15/20 Criteo continues slide as risk from Google cookie changes seen persisting PRSP Perspecta $22.93 / -0.4 (-1.71%) 02/06/20 Perspecta slides, Leidos rises after Navy awards 'huge' internet contract PANW Palo Alto Networks $229.36 / -4.89 (-2.09%) 02/25/20 Street Fight: Palo Alto sees many downgrades, some defenses after guidance cut 02/22/20 Week in Review: How Trump's policies moved stocks 01/14/20 Apple downgrade, Tesla price target raises among today's top Wall Street calls 11/26/19 Fly Intel: Wall Street's top stories at midday NYMT New York Mortgage $2.04 / +0.105 (+5.43%) 03/24/20 Fly Intel: Wall Street's top stories for Tuesday NVDA Nvidia $351.01 / -7.78 (-2.17%) 05/21/20 Lowe's upgrade, Square downgrade among today's top calls on Wall Street 05/19/20 Game On: NPD reports record consumer video game spend in Q1 05/19/20 Fly Intel: What to watch in Nvidia earnings report 05/18/20 Nvidia upgrade, Square downgrades among today's top calls on Wall Street LGF.A Lionsgate $8.61 / +0.13 (+1.53%) 03/15/20 Box Office Battle: 'Onward' wins weekend as revenue hits 20-year low 03/13/20 Box Office Battle: 'Bloodshot' hits theaters as AMC halves theater capacity 03/08/20 Box Office Battle: 'Onward' wins weekend with muted $40M U.S. debut 03/06/20 Box Office Battle: 'Onward' expected to push past 'The Invisible Man,' 'Sonic' INTU Intuit $290.30 / -0.4 (-0.14%) 05/07/20 Fly Intel: After-Hours Movers 03/26/20 Fly Intel: Micron double upgrade among today's top calls on Wall Street 03/14/20 Week in Review: How Trump's policies moved stocks 03/11/20 United, Delta Air Lines downgrades among today's top calls on Wall Street HPE HP Enterprise $10.35 / +0.07 (+0.68%) 03/31/20 Fly Intel: Wendy's, Dollar General upgrades among top calls on Wall Street 03/04/20 Fly Intel: Wall Street's top stories for Wednesday 03/04/20 Fly Intel: Wall Street's top stories at midday 03/04/20 Fly Intel: Pre-market Movers H Hyatt $53.45 / -0.49 (-0.91%) 05/06/20 Fly Intel: After-Hours Movers 03/21/20 Week in Review: How Trump's policies moved stocks 03/18/20 Fly Intel: Wall Street's top stories for Wednesday 03/03/20 Fly Intel: Wall Street's top stories for Tuesday ELF e.l.f. Beauty $14.56 / +0.34 (+2.39%) 02/04/20 Tesla downgrade, Comcast upgrade among today's top analyst calls 01/27/20 Wynn, Estee Lauder, Intel downgrades among today's top analyst calls 12/03/19 Fly Intel: Wall Street's top stories at midday DECK Deckers Brands $167.93 / +5.83 (+3.60%) 01/31/20 Fly Intel: Wall Street's top stories for Friday 01/31/20 Fly Intel: Wall Street's top stories at midday 11/26/19 Chipotle's $970 price target among today's top calls on Wall Street 11/25/19 Netflix downgrade to Underperform among today's top analyst calls CHUY Chuy's $16.13 / +0.09 (+0.56%) 04/23/20 Fly Intel: Apple downgrade, Chipotle upgrade among top calls on Wall Street 11/22/19 Uber, International Flavors upgrades among today's top analyst calls A Agilent $80.84 / -0.83 (-1.02%) 02/24/20 Plethora of downgrades among today's top analyst calls 05/27/20 17th Annual Institutional Investor Virtual Conference 06/01/20 2020 Cloud Secular Winners Virtual Conference 06/05/20 40th Annual Consumer Marketplace Virtual Conference 06/08/20 Virtual Software & Semiconductor Bus Tour 06/12/20 FBN Silicon Valley Tech Virtual Tour 06/15/20 42nd Nasdaq Investor Conference 09/14/20 ShopTalk 2020 05/21/20 Ross Stores - ROST 05/21/20 Agilent - A 05/21/20 Intuit - INTU 05/21/20 LiveRamp - RAMP 05/21/20 Splunk - SPLK 05/21/20 Palo Alto Networks - PANW 05/21/20 e.l.f. Beauty - ELF 05/21/20 Agilysys - AGYS 05/21/20 Deckers Brands - DECK 05/21/20 ePlus - PLUS 05/21/20 Perspecta - PRSP 05/21/20 HP Enterprise - HPE 05/21/20 Lionsgate - LGF.A 05/21/20 Chuy's - CHUY 05/21/20 Nvidia - NVDA 05/22/20 New York Mortgage - NYMT 05/22/20 America's Car-Mart - CRMT 05/28/20 Geron - GERN 06/05/20 Geron Corporation 06/09/20 Syndax Pharmaceuticals, Inc. 06/09/20 NVIDIA Corp. 06/11/20 Splunk Inc. SPLK ROST PANW NYMT NVDA INTU HPE H A SPLK Splunk $163.27 / +0.11 (+0.07%) 05/21/20 Splunk options imply 9.9% move in share price post-earnings 03/04/20 Splunk options imply 13.5% move in share price post-earnings 11/25/19 Splunk call volume above normal and directionally bullish ROST Ross Stores $97.01 / +6.1 (+6.71%) 05/21/20 Early notable gainers among liquid option names on May 21st 01/09/20 Early notable gainers among liquid option names on January 9th PANW Palo Alto Networks $229.36 / -4.89 (-2.09%) 05/21/20 Palo Alto Networks options imply 8.4% move in share price post-earnings 02/24/20 Palo Alto Networks options imply 11.6% move in share price post-earnings 12/11/19 Palo Alto Networks call volume above normal and directionally bullish 12/03/19 Largest borrow rate increases among liquid names NYMT New York Mortgage $2.04 / +0.105 (+5.43%) 03/27/20 Unusual call flow in option market yesterday 03/26/20 Call volume 22x normal in REIT New York Mortgage Trust NVDA Nvidia $351.01 / -7.78 (-2.17%) 05/21/20 NVIDIA options imply 8.7% move in share price post-earnings 05/19/20 Early notable gainers among liquid option names on May 19th 05/13/20 Early notable gainers among liquid option names on May 13th 05/07/20 Unusually active option classes on open May 7th INTU Intuit $290.30 / -0.4 (-0.14%) 11/26/19 Early notable gainers among liquid option names on November 26th HPE HP Enterprise $10.35 / +0.07 (+0.68%) 05/21/20 Hewlett Packard Enterprise options imply 8.3% move in share price post-earnings 04/23/20 Hewlett Packard Enterprise put volume heavy and directionally bearish 03/24/20 Hewlett Packard Enterprise call volume above normal and directionally bullish 03/04/20 Hewlett Packard Enterprise put volume heavy and directionally bearish H Hyatt $53.45 / -0.49 (-0.91%) 05/06/20 Hyatt put volume heavy and directionally bearish 04/17/20 Largest borrow rate increases among liquid names 04/09/20 Unusual put flow in option market yesterday 04/08/20 Hyatt put buyer paying 1.50 for May 35s A Agilent $80.84 / -0.83 (-1.02%) 02/20/20 Agilent put volume heavy and directionally bearish 12/30/19 Agilent call volume above normal and directionally bullish 11/27/19 Largest borrow rate increases among liquid names
Hot Stocks	Agilent up 5% to $84.70 after Q2 results beat estimates 16:47 05/21/20 05/21 16:47 05/21/20 16:47 A Agilent $80.84 / -0.83 (-1.02%) ShowHide Related Items >><< Company News Street Research Earnings Periodicals On The Fly Events Options A Agilent $80.84 / -0.83 (-1.02%) 05/18/20 Agilent PD-L1 assay receives FDA approval for use as companion diagnostic 05/15/20 Ackman's Pershing Square adds Blackstone, cuts Chipotle in Q1 05/15/20 FDA approves Agilent PD-L1 diagnostic device for lung cancer 04/23/20 Agilent announces FDA approval of PD-L1 companion diagnostic A Agilent $80.84 / -0.83 (-1.02%) 03/30/20 Wells Fargo Agilent price target lowered to $82 from $100 at Wells Fargo 02/24/20 Needham Agilent downgraded to Hold from Buy at Needham 02/24/20 Needham Agilent downgraded to Hold from Buy at Needham 02/19/20 Piper Sandler Agilent price target raised to $96 from $86 at Piper Sandler A Agilent $80.84 / -0.83 (-1.02%) 05/21/20 Agilent reports Q2 adjusted EPS 71c, consensus 61c 02/18/20 Agilent backs FY20 adjusted EPS view $3.38-$3.43, consensus $3.42 02/18/20 Agilent sees Q2 adjusted EPS 72c-76c, consensus 79c 02/18/20 Agilent reports Q1 adjusted EPS 81c, consensus 81c A Agilent $80.84 / -0.83 (-1.02%) 02/08/20 Sustainable companies in America beating the market, Barron's says A Agilent $80.84 / -0.83 (-1.02%) 02/24/20 Plethora of downgrades among today's top analyst calls 05/21/20 Agilent - A A Agilent $80.84 / -0.83 (-1.02%) 02/20/20 Agilent put volume heavy and directionally bearish 12/30/19 Agilent call volume above normal and directionally bullish 11/27/19 Largest borrow rate increases among liquid names
Earnings	Agilent reports Q2 adjusted EPS 71c, consensus 61c » 16:09 05/21/20 05/21 16:09 05/21/20 16:09 A Agilent $80.77 / -0.9 (-1.10%) Reports Q2 revenue… Reports Q2 revenue $1.24B, consensus $1.21B. "Our business was tracking well into late March when we experienced significant disruption in the U.S. and Europe as customers closed or restricted access to their facilities to slow the spread of COVID-19," said Mike McMullen, Agilent president and CEO. "I'm incredibly proud of how the Agilent team has taken quick, decisive action to ensure the safety of our employees, keep our operations up and running efficiently, and support our customers around the world. I believe we are well-positioned to face the challenges brought on by COVID-19 given our focus on growth, a resilient business model, a strong balance sheet, and most importantly, our outstanding team." ShowHide Related Items >><< Company News Street Research Earnings Periodicals On The Fly Events Options A Agilent $80.77 / -0.9 (-1.10%) 05/18/20 Agilent PD-L1 assay receives FDA approval for use as companion diagnostic 05/15/20 Ackman's Pershing Square adds Blackstone, cuts Chipotle in Q1 05/15/20 FDA approves Agilent PD-L1 diagnostic device for lung cancer 04/23/20 Agilent announces FDA approval of PD-L1 companion diagnostic A Agilent $80.77 / -0.9 (-1.10%) 03/30/20 Wells Fargo Agilent price target lowered to $82 from $100 at Wells Fargo 02/24/20 Needham Agilent downgraded to Hold from Buy at Needham 02/24/20 Needham Agilent downgraded to Hold from Buy at Needham 02/19/20 Piper Sandler Agilent price target raised to $96 from $86 at Piper Sandler A Agilent $80.77 / -0.9 (-1.10%) 02/18/20 Agilent backs FY20 adjusted EPS view $3.38-$3.43, consensus $3.42 02/18/20 Agilent sees Q2 adjusted EPS 72c-76c, consensus 79c 02/18/20 Agilent reports Q1 adjusted EPS 81c, consensus 81c 02/18/20 Notable companies reporting after market close A Agilent $80.77 / -0.9 (-1.10%) 02/08/20 Sustainable companies in America beating the market, Barron's says A Agilent $80.77 / -0.9 (-1.10%) 02/24/20 Plethora of downgrades among today's top analyst calls 05/21/20 Agilent - A A Agilent $80.77 / -0.9 (-1.10%) 02/20/20 Agilent put volume heavy and directionally bearish 12/30/19 Agilent call volume above normal and directionally bullish 11/27/19 Largest borrow rate increases among liquid names

Hot Stocks	Agilent PD-L1 assay receives FDA approval for use as companion diagnostic » 08:08 05/18/20 05/18 08:08 05/18/20 08:08 A Agilent $81.52 / -0.07 (-0.09%) , BMY Bristol-Myers $64.19 / +0.38 (+0.60%) Agilent Technologies (A)… Agilent Technologies (A) announced that the FDA has approved the company's PD-L1 IHC 28-8 pharmDx for expanded use in non-small cell lung cancer, or NSCLC. Agilent developed PD-L1 IHC 28-8 pharmDx in 2016 through a collaboration with Bristol Myers Squibb (BMY), and it has been previously approved as a complementary in vitro diagnostic for non-squamous non-small cell lung cancer, as well as other forms of cancer, including, squamous cell carcinoma of the head and neck, and urothelial carcinoma. ShowHide Related Items >><< Company News Street Research Earnings Periodicals On The Fly Events Options BMY A BMY Bristol-Myers $64.19 / +0.38 (+0.60%) 05/15/20 Bristol-Myers reports FDA approval for fifth indication for Opdivo + Yervoy 05/15/20 FDA approves Bristol-Myers combo for metastatic non-small cell lung cancer 05/15/20 Bristol-Myers receives FDA approval for Pomalyst 05/14/20 Heat Biologics to present Phase 2 lung cancer trial data at ASCO A Agilent $81.52 / -0.07 (-0.09%) 05/15/20 Ackman's Pershing Square adds Blackstone, cuts Chipotle in Q1 05/15/20 FDA approves Agilent PD-L1 diagnostic device for lung cancer 04/23/20 Agilent announces FDA approval of PD-L1 companion diagnostic 04/22/20 Agilent becomes sponsor of My Green Lab nonprofit A BMY A Agilent $81.52 / -0.07 (-0.09%) 03/30/20 Wells Fargo Agilent price target lowered to $82 from $100 at Wells Fargo 02/24/20 Needham Agilent downgraded to Hold from Buy at Needham 02/24/20 Needham Agilent downgraded to Hold from Buy at Needham 02/19/20 Piper Sandler Agilent price target raised to $96 from $86 at Piper Sandler BMY Bristol-Myers $64.19 / +0.38 (+0.60%) 05/13/20 Stifel Bluebird's ide-cel remains approvable despite FDA's 'strict stance,' says Stifel 05/13/20 Piper Sandler Bluebird should be able to easily address RTF issues, says Piper Sandler 05/12/20 Oppenheimer Bluebird Bio price target lowered to $111 from $122 at Oppenheimer 04/20/20 Piper Sandler Exelixis combo approval would increase kidney cancer use, says Piper Sandler BMY A BMY Bristol-Myers $64.19 / +0.38 (+0.60%) 05/07/20 Bristol-Myers sees FY20 revenue $40B-$42B, consensus $41.65B 05/07/20 Bristol-Myers affirms FY21 adjusted EPS view $7.15-$7.45, consensus $7.38 05/07/20 Bristol-Myers affirms FY20 adjusted EPS view $6.00-$5.20, consensus $6.17 05/07/20 Bristol-Myers reports Q1 adjusted EPS $1.72, consensus $1.49 A Agilent $81.52 / -0.07 (-0.09%) 02/18/20 Agilent backs FY20 adjusted EPS view $3.38-$3.43, consensus $3.42 02/18/20 Agilent sees Q2 adjusted EPS 72c-76c, consensus 79c 02/18/20 Agilent reports Q1 adjusted EPS 81c, consensus 81c 02/18/20 Notable companies reporting after market close BMY A BMY Bristol-Myers $64.19 / +0.38 (+0.60%) 02/01/20 Oracle, Discovery still looking cheap, Barron's says 01/03/20 Novartis, Merck, Allergan raise U.S. prices on over 100 drugs, Reuters reports 12/13/19 Bristol-Myers awarded $585M in damages in patent win over Gilead, Bloomberg says 12/13/19 Bristol-Myers awarded $585M in damages in patent win over Gilead, Bloomberg says A Agilent $81.52 / -0.07 (-0.09%) 02/08/20 Sustainable companies in America beating the market, Barron's says BMY A BMY Bristol-Myers $64.19 / +0.38 (+0.60%) 05/07/20 Fly Intel: Pre-market Movers 05/06/20 Novo Nordisk slips as analysts discuss NASH data, read-through to peers 04/20/20 Fly Intel: Wall Street's top stories for Monday 04/20/20 Fly Intel: Wall Street's top stories at midday A Agilent $81.52 / -0.07 (-0.09%) 02/24/20 Plethora of downgrades among today's top analyst calls 05/21/20 Agilent - A 08/06/20 PDUFA Date for CM-9LA Opdivo + Yervoy 08/17/20 PDUFA Date for Lisocabtagene Maraleucel (liso-cel) 09/03/20 PDUFA Date for CC-486 BMY A BMY Bristol-Myers $64.19 / +0.38 (+0.60%) 05/01/20 Bristol Myers Squibb put volume heavy and directionally bearish 04/20/20 Bristol Myers Squibb call volume above normal and directionally bullish 04/20/20 Early notable gainers among liquid option names on April 20th 03/30/20 Unusually active option classes on open March 30th A Agilent $81.52 / -0.07 (-0.09%) 02/20/20 Agilent put volume heavy and directionally bearish 12/30/19 Agilent call volume above normal and directionally bullish 11/27/19 Largest borrow rate increases among liquid names
Hot Stocks	Ackman's Pershing Square adds Blackstone, cuts Chipotle in Q1 » 16:42 05/15/20 05/15 16:42 05/15/20 16:42 BX Blackstone $51.10 / +0.53 (+1.05%) , PK Park Hotels & Resorts $7.32 / + (+0.00%) , A Agilent $81.52 / -0.07 (-0.09%) , HHC Howard Hughes $42.58 / -1.24 (-2.83%) , SBUX Starbucks $74.16 / -0.08 (-0.11%) , BRK.B Berkshire Hathaway $169.41 / -1.5 (-0.88%) , LOW Lowe's $113.87 / +3.46 (+3.13%) , CMG Chipotle $973.22 / +42.01 (+4.51%) , HLT Hilton $68.63 / +0.52 (+0.76%) Bill Ackman's… Bill Ackman's Pershing Square Capital disclosed in an SEC filing its holdings as of March 31, 2020. The fund's two new buys during the first quarter included, by size of position, Blackstone (BX) and Park Hotels & Resorts (PK). Pershing increased its stake in six positions during the quarter, including by size of previous position Agilent (A), Howard Hughes (HHC), Starbucks (SBUX), Berkshire Hathaway Class B (BRK.B), and Lowe's (LOW). The fund decreased its stake in one holding, namely Chipotle (CMG). Pershing's top holdings as of March 31, in order of size, were Lowe's, Berkshire Hathaway Class B, Hilton Worldwide (HLT), Agilent, and Chipotle. ShowHide Related Items >><< Company News Street Research Earnings Periodicals On The Fly Events Options SBUX PK LOW HLT HHC CMG BX BRK.B A SBUX Starbucks $74.16 / -0.08 (-0.11%) 05/11/20 Starbucks to begin phased reopening of drive-thru stores across U.K. on May 14 05/07/20 Uber Eats adds 'share a delivery' to send treats to friends and family 05/04/20 Starbucks sees more than 85% of company-operated U.S. stores reopened by May 9 05/04/20 Starbucks downgraded to BBB at Fitch; outlook negative PK Park Hotels & Resorts $7.32 / + (+0.00%) 04/06/20 Park Hotels & Resorts trading resumes 04/06/20 Park Hotels & Resorts trading halted, volatility trading pause 03/30/20 Park Hotels & Resorts trading resumes 03/30/20 Park Hotels & Resorts trading halted, volatility trading pause LOW Lowe's $113.87 / +3.46 (+3.13%) 05/04/20 Lowe's Canada extends temporary hourly wage premium throughout May 05/04/20 Lowe's announces second $80M special payment to hourly associates 04/09/20 ToughBuilt awarded over $22M in new business from Lowe's 04/07/20 Lowe's announces stores will close on Easter Sunday, April 12 HLT Hilton $68.63 / +0.52 (+0.76%) 05/15/20 Lone Pine buys Visa, exits Salesforce in Q1 05/07/20 Hilton reports Q1 system-wide comparable RevPAR decreased 22.6% 05/05/20 American Express, Hilton donate 1M hotel room nights to medical professionals 05/04/20 Choice Hotels announces 'Commitment to Clean' initiative HHC Howard Hughes $42.58 / -1.24 (-2.83%) 04/06/20 Pershing boosts stake in Berkshire by 39%, Lowe's by 46% 03/18/20 Howard Hughes sells MD Anderson The Woodlands medical building for $115M 02/14/20 Pershing Square boosts Howard Hughes stake, lowers Starbucks stake 12/30/19 Howard Hughes acquires office space, land from Occidental CMG Chipotle $973.22 / +42.01 (+4.51%) 05/14/20 Chipotle partners with Uber Eats in Canada 04/26/20 Fly Intel: Top five weekend stock stories 04/21/20 Chipotle rises 4.2% after reporting Q1 results, withdrawing FY20 guidance 04/21/20 Chipotle reports Q1 digital sales up 80.8% to $371.8M BX Blackstone $51.10 / +0.53 (+1.05%) 04/29/20 Energy Transfer LP jumps 6% to $8.60 after Blackstone reports stake 04/29/20 Blackstone Holdings reports 6.9% passive stake in Energy Transfer LP 04/23/20 Blackstone cuts dividend to 39c per share 04/16/20 Nokia jumps following report of takeover defense BRK.B Berkshire Hathaway $169.41 / -1.5 (-0.88%) 05/04/20 Buffett sold stakes in U.S. airlines with world 'changed' due to COVID-19 05/02/20 Berkshire says 69% of securities held in Apple, four other companies 05/02/20 Berkshire Hathaway bought back $1.7B of shares in Q1 05/02/20 Berkshire concluded impairment loss on Kraft investment not required A Agilent $81.52 / -0.07 (-0.09%) 05/15/20 FDA approves Agilent PD-L1 diagnostic device for lung cancer 04/23/20 Agilent announces FDA approval of PD-L1 companion diagnostic 04/22/20 Agilent becomes sponsor of My Green Lab nonprofit 04/14/20 Agilent withdraws Q2, FY20 guidance due to COVID-19 BX PK A HHC SBUX BRK.B LOW CMG HLT BX Blackstone $51.10 / +0.53 (+1.05%) 04/24/20 Citi Blackstone price target raised to $57.50 from $53.50 at Citi 04/15/20 Wells Fargo Blackstone price target lowered to $62 from $70 at Wells Fargo 04/14/20 Nomura Instinet Alnylam risks not absolved with Blackstone deal, says Nomura Instinet 03/19/20 Citi Blackstone upgraded to Buy from Neutral at Citi PK Park Hotels & Resorts $7.32 / + (+0.00%) 04/07/20 Wells Fargo Park Hotels & Resorts downgraded to Underweight from Equal Weight at Wells Fargo 04/07/20 Citi Park Hotels & Resorts downgraded to Sell from Neutral at Citi 03/30/20 Jefferies Jefferies upgrades Host and Sunstone, downgrades Park Hotels in REIT reorg 03/30/20 Jefferies Park Hotels & Resorts downgraded to Hold from Buy at Jefferies A Agilent $81.52 / -0.07 (-0.09%) 03/30/20 Wells Fargo Agilent price target lowered to $82 from $100 at Wells Fargo 02/24/20 Needham Agilent downgraded to Hold from Buy at Needham 02/24/20 Needham Agilent downgraded to Hold from Buy at Needham 02/19/20 Piper Sandler Agilent price target raised to $96 from $86 at Piper Sandler HHC Howard Hughes $42.58 / -1.24 (-2.83%) 03/31/20 BWS Financial Howard Hughes price target lowered to $80 from $150 at BWS Financial 03/26/20 Fly Intel: Top five analyst downgrades 03/26/20 Piper Sandler Howard Hughes downgraded to Neutral from Overweight at Piper Sandler 12/31/19 BWS Financial Howard Hughes share price not reflective of cash flow power, says BWS Financial SBUX Starbucks $74.16 / -0.08 (-0.11%) 04/29/20 JPMorgan Starbucks shares have 'overshot' near-term results, says JPMorgan 04/29/20 Stephens Starbucks price target lowered to $72 from $80 at Stephens 04/29/20 Piper Sandler Piper Sandler still 'paused' on Starbucks shares after Q1 results 04/29/20 Barclays Starbucks price target lowered to $92 from $97 at Barclays BRK.B Berkshire Hathaway $169.41 / -1.5 (-0.88%) LOW Lowe's $113.87 / +3.46 (+3.13%) 05/14/20 Fly Intel: Top five analyst downgrades 05/14/20 Cleveland Research Homecenters had strong end of April, start to May, says Cleveland Research 05/14/20 Evercore ISI Lowe's downgraded to In Line from Outperform at Evercore ISI 05/12/20 Wells Fargo Lowe's price target raised to $130 from $110 at Wells Fargo CMG Chipotle $973.22 / +42.01 (+4.51%) 05/14/20 Piper Sandler Chipotle price target raised to $1,100 from $850 at Piper Sandler 04/24/20 Stifel Papa John's price target raised to $80 from $65 at Stifel 04/23/20 Fly Intel: Top five analyst upgrades 04/23/20 RBC Capital Chipotle price target raised to $783 from $727 at RBC Capital HLT Hilton $68.63 / +0.52 (+0.76%) 05/11/20 Raymond James Hilton price target raised to $82 from $77 at Raymond James 05/08/20 Deutsche Bank Hilton price target lowered to $74 from $103 at Deutsche Bank 04/22/20 BofA Choice Hotels upgraded to Neutral from Underperform at Bofa 04/14/20 Barclays Investors should start preparing to buy lodging stocks, says Barclays SBUX PK LOW HLT HHC CMG BX BRK.B A SBUX Starbucks $74.16 / -0.08 (-0.11%) 04/28/20 Starbucks says FY20 guidance to remain suspended 04/28/20 Starbucks sees FY20 China comparable store sales growth down 15% to down 25% 04/28/20 Starbucks sees Q4 China comparable store sales growth down 10% to flat 04/28/20 Starbucks sees FY20 China SSS growth (25%)-(15%) PK Park Hotels & Resorts $7.32 / + (+0.00%) 05/11/20 Park Hotels & Resorts reports Q1 AFFO 24c, consensus 14c 03/09/20 Park Hotels & Resorts withdraws FY20 guidance due to COVID-19 uncertainty 02/26/20 Park Hotels & Resorts sees FY20 EPS $1.12-$1.24, consensus $1.40. 02/26/20 Park Hotels & Resorts reports Q4 EPS 51c, consensus 33c LOW Lowe's $113.87 / +3.46 (+3.13%) 02/26/20 Lowe's sees FY20 adj. EPS $6.45-$6.58, consensus $6.67 02/26/20 Lowe's reports Q4 adj. EPS 94c, consensus 91c 02/25/20 Notable companies reporting before tomorrow's open HLT Hilton $68.63 / +0.52 (+0.76%) 05/07/20 Hilton reports Q1 adjusted EPS 74c, consensus 57c 05/06/20 Notable companies reporting before tomorrow's open 03/10/20 Hilton withdraws Q1, FY20 guidance due to COVID-19 impact HHC Howard Hughes $42.58 / -1.24 (-2.83%) 05/11/20 Howard Hughes reports Q1 EPS ($2.88) vs. 74c last year 02/27/20 Howard Hughes reports Q4 EPS (3c), consensus (40c) CMG Chipotle $973.22 / +42.01 (+4.51%) 04/21/20 Chipotle withdraws prior FY20 guidance 04/21/20 Chipotle withdraws prior FY20 guidance 04/21/20 Chipotle reports Q1 adjusted EPS $3.08, consensus $2.90 04/21/20 Notable companies reporting after market close BX Blackstone $51.10 / +0.53 (+1.05%) 04/23/20 Blackstone reports Q1 distributable EPS 46c, consensus 50c 04/22/20 Notable companies reporting before tomorrow's open 01/30/20 Blackstone reports Q4 distributable EPS 72c, consensus 66c BRK.B Berkshire Hathaway $169.41 / -1.5 (-0.88%) 05/02/20 Berkshire Hathaway reports Q1 net loss $49.75B vs. $21.66B gain last year 02/22/20 Berkshire Hathaway reports Q4 net earnings $4.42B vs. $5.72B last year A Agilent $81.52 / -0.07 (-0.09%) 02/18/20 Agilent backs FY20 adjusted EPS view $3.38-$3.43, consensus $3.42 02/18/20 Agilent sees Q2 adjusted EPS 72c-76c, consensus 79c 02/18/20 Agilent reports Q1 adjusted EPS 81c, consensus 81c 02/18/20 Notable companies reporting after market close SBUX HLT CMG BX BRK.B A SBUX Starbucks $74.16 / -0.08 (-0.11%) 05/14/20 Starbucks wants landlords to lower rent for at least a year, Seattle Times says 04/25/20 Risks may be too great to chow down on restaurant stocks, Barron's says 04/21/20 Starbucks to debut Beyond Meat products in China, CNBC reports 04/05/20 Luckin Coffee business to continue amid financial fraud probe, Reuters reports HLT Hilton $68.63 / +0.52 (+0.76%) 03/22/20 Marriott furloughing thousands of corporate employees, WSJ reports 03/18/20 NYC may turn hotels into hospitals for non-Covid patients, WSJ says 03/18/20 Hotel industry asks Trump administration for $150B bailout, WSJ reports 03/11/20 Hilton to draw down part of $1.75B credit line amid virus crisis, Bloomberg says CMG Chipotle $973.22 / +42.01 (+4.51%) 04/03/20 Chipotle CEO tells CNBC new menu items to be delayed due to COVID-19 12/20/19 Chipotle accused of labor law violations on union organizing, Reuters says BX Blackstone $51.10 / +0.53 (+1.05%) 05/13/20 Blackstone in talks for joint bid on eBay classifieds unit, Dealreporter says 05/05/20 Blackstone, CVC weigh investments in Serie A football league, FT reports 04/14/20 Trump to discuss U.S. economy restart with Walmart, Exxon CEOs, Bloomberg says 03/24/20 Trump held call on economy with finance leaders, hedge funds, CNBC reports BRK.B Berkshire Hathaway $169.41 / -1.5 (-0.88%) 05/10/20 Amazon/Berkshire/JPMorgan healthcare venture looking for new CEO, WSJ says 05/04/20 Berkshires' Buffett ponders workers return to offices, WSJ says 04/20/20 Occidental shareholders to vote on financing for Anadarko deal, Reuters reports 03/13/20 Buffett says 'won't be selling airline stocks', Yahoo Finance reports A Agilent $81.52 / -0.07 (-0.09%) 02/08/20 Sustainable companies in America beating the market, Barron's says SBUX LOW HLT HHC CMG BX BRK.B A SBUX Starbucks $74.16 / -0.08 (-0.11%) 05/05/20 Fly Intel: What to watch in Beyond Meat earnings report 04/29/20 Fly Intel: Wall Street's top stories for Wednesday 04/29/20 Fly Intel: Wall Street's top stories at midday 04/28/20 Fly Intel: After-Hours Movers LOW Lowe's $113.87 / +3.46 (+3.13%) 04/22/20 Fly Intel: Netflix upgrade, 2 downgrades among today's top calls on Wall Street 04/07/20 Fly Intel: GM downgrade, Lowe's upgrade among today's top calls on Wall Street 02/26/20 Fly Intel: Wall Street's top stories for Wednesday 02/26/20 Fly Intel: Wall Street's top stories at midday HLT Hilton $68.63 / +0.52 (+0.76%) 05/07/20 Fly Intel: Pre-market Movers 04/09/20 Fly Intel: Starbucks downgrade, initiation among today's top Wall Street calls 03/30/20 Fly Intel: Alphabet upgrade among today's top calls on Wall Street 03/23/20 Fly Intel: Wall Street's top stories for Monday HHC Howard Hughes $42.58 / -1.24 (-2.83%) 12/09/19 Fly Insider: Kodak, Dicerna among week's notable insider trades CMG Chipotle $973.22 / +42.01 (+4.51%) 04/23/20 Fly Intel: Apple downgrade, Chipotle upgrade among top calls on Wall Street 04/22/20 Fly Intel: Wall Street's top stories for Wednesday 04/22/20 Fly Intel: Wall Street's top stories at midday 04/22/20 Fly Intel: Pre-market Movers BX Blackstone $51.10 / +0.53 (+1.05%) 04/30/20 Fly Intel: Wall Street's top stories for Thursday 04/30/20 Fly Intel: Wall Street's top stories at midday 04/23/20 Fly Intel: Wall Street's top stories for Thursday 04/23/20 Fly Intel: Wall Street's top stories at midday BRK.B Berkshire Hathaway $169.41 / -1.5 (-0.88%) 05/04/20 Fly Intel: Wall Street's top stories for Monday 05/04/20 Fly Intel: Pre-market Movers 04/06/20 Fly Intel: Wall Street's top stories at midday 02/24/20 Fly Intel: Wall Street's top stories for Monday A Agilent $81.52 / -0.07 (-0.09%) 02/24/20 Plethora of downgrades among today's top analyst calls 09/14/20 ShopTalk 2020 05/20/20 Lowe's - LOW 05/21/20 Agilent - A 05/19/20 Chipotle Mexican Grill, Inc. 05/19/20 Chipotle Mexican Grill, Inc. 05/29/20 Lowe's Companies Inc. 06/05/20 Hilton Worldwide Holdings Inc SBUX PK LOW HLT CMG BX A SBUX Starbucks $74.16 / -0.08 (-0.11%) 04/09/20 Starbucks put volume heavy and directionally bearish 04/03/20 Starbucks put volume heavy and directionally bearish 04/02/20 Unusually active option classes on open April 2nd 03/23/20 Starbucks put volume heavy and directionally bearish PK Park Hotels & Resorts $7.32 / + (+0.00%) 04/29/20 Park Hotels & Resorts call volume above normal and directionally bullish LOW Lowe's $113.87 / +3.46 (+3.13%) 04/16/20 Lowe's put volume heavy and directionally bearish 04/01/20 Lowe's put volume heavy and directionally bearish 03/30/20 Lowe's put volume heavy and directionally bearish 02/26/20 Unusually active option classes on open February 26th HLT Hilton $68.63 / +0.52 (+0.76%) 05/01/20 Hilton put volume heavy and directionally bearish 02/26/20 Hilton put volume heavy and directionally bearish 02/25/20 Hilton put volume heavy and directionally bearish 02/06/20 Hilton put volume heavy and directionally bearish CMG Chipotle $973.22 / +42.01 (+4.51%) 04/22/20 Early notable gainers among liquid option names on April 22nd 04/21/20 Chipotle options imply 14.4% move in share price post-earnings 04/01/20 Unusually active option classes on open April 1st 02/04/20 Chipotle options imply 10.3% move in share price post-earnings BX Blackstone $51.10 / +0.53 (+1.05%) 03/18/20 Blackstone put volume heavy and directionally bearish A Agilent $81.52 / -0.07 (-0.09%) 02/20/20 Agilent put volume heavy and directionally bearish 12/30/19 Agilent call volume above normal and directionally bullish 11/27/19 Largest borrow rate increases among liquid names
Hot Stocks	FDA approves Agilent PD-L1 diagnostic device for lung cancer » 14:25 05/15/20 05/15 14:25 05/15/20 14:25 A Agilent $81.55 / -0.04 (-0.05%) the Food and Drug… the Food and Drug Administration today approved the PD-L1 IHC 28-8 pharmDx from Agilent Technologies as a companion diagnostic device for selecting patients with metastatic non-small cell lung cancer for treatment with nivolumab plus ipilimumab. Reference Link ShowHide Related Items >><< Company News Street Research Earnings Periodicals On The Fly Events Options A Agilent $81.55 / -0.04 (-0.05%) 04/23/20 Agilent announces FDA approval of PD-L1 companion diagnostic 04/22/20 Agilent becomes sponsor of My Green Lab nonprofit 04/14/20 Agilent withdraws Q2, FY20 guidance due to COVID-19 04/06/20 Pershing boosts stake in Berkshire by 39%, Lowe's by 46% A Agilent $81.55 / -0.04 (-0.05%) 03/30/20 Wells Fargo Agilent price target lowered to $82 from $100 at Wells Fargo 02/24/20 Needham Agilent downgraded to Hold from Buy at Needham 02/24/20 Needham Agilent downgraded to Hold from Buy at Needham 02/19/20 Piper Sandler Agilent price target raised to $96 from $86 at Piper Sandler A Agilent $81.55 / -0.04 (-0.05%) 02/18/20 Agilent backs FY20 adjusted EPS view $3.38-$3.43, consensus $3.42 02/18/20 Agilent sees Q2 adjusted EPS 72c-76c, consensus 79c 02/18/20 Agilent reports Q1 adjusted EPS 81c, consensus 81c 02/18/20 Notable companies reporting after market close A Agilent $81.55 / -0.04 (-0.05%) 02/08/20 Sustainable companies in America beating the market, Barron's says A Agilent $81.55 / -0.04 (-0.05%) 02/24/20 Plethora of downgrades among today's top analyst calls 05/21/20 Agilent - A A Agilent $81.55 / -0.04 (-0.05%) 02/20/20 Agilent put volume heavy and directionally bearish 12/30/19 Agilent call volume above normal and directionally bullish 11/27/19 Largest borrow rate increases among liquid names
Conference/Events	American Society of Gene & Cell Therapy to hold virtual meeting » 05:55 05/15/20 05/15 05:55 05/15/20 05:55 A Agilent $81.59 / +1.44 (+1.80%) , ABEO Abeona Therapeutics $3.21 / -0.065 (-1.98%) , ADVM Adverum Biotechnologies $17.20 / -0.18 (-1.04%) , AGEEF Halo Labs $0.00 / + (+0.00%) , AVRO Avrobio $15.58 / -1.19 (-7.10%) , BIO Bio-Rad $455.80 / +2.52 (+0.56%) , BMRN BioMarin $91.67 / -3.01 (-3.18%) , CRL Charles River $163.30 / +3.07 (+1.92%) , CTLT Catalent $70.04 / -1.08 (-1.52%) , MGTA Magenta Therapeutics $8.67 / -0.305 (-3.40%) , PI Impinj $22.94 / +1.01 (+4.61%) , QURE uniQure $56.16 / -0.56 (-0.99%) , SRPT Sarepta $127.15 / -1.08 (-0.84%) , TECH Bio-Techne $261.68 / -0.7 (-0.27%) , TMO Thermo Fisher $336.49 / +2.31 (+0.69%) , RARE Ultragenyx $64.57 / +0.44 (+0.69%) 23rd Annual Virtual… 23rd Annual Virtual Meeting of ASGCT 2020 will be held May 12-15. Webcast Link ShowHide Related Items >><< Company News Street Research Earnings Periodicals On The Fly Events Options TMO TECH SRPT RARE QURE PI MGTA CTLT CRL BMRN BIO AVRO ADVM ABEO A TMO Thermo Fisher $336.49 / +2.31 (+0.69%) 05/13/20 Thermo Fisher to develop antibodies test with WuXi Diagnostics, Mayo Clinic 05/12/20 Thermo Fisher: FDA further expands EUA for multiplex real-time PCR test 05/04/20 DNA Genotek's ORAcollectRNA kit included in EUA granted to Biocerna SARS-CoV-2 04/22/20 Thermo Fisher up 3% after earnings beat, discussing COVID testing tailwinds TECH Bio-Techne $261.68 / -0.7 (-0.27%) 04/30/20 Bio-Techne announces update, develops resources for SARS-CoV-2 detection 03/25/20 Bio-Techne's Ella panel utilized in COVID-19 patient monitoring 03/18/20 Bio-Techne's Exosome Diagnostics laboratory receives contract from GSA 02/05/20 Bio-Techne announces availability of next generation ELISA kits SRPT Sarepta $127.15 / -1.08 (-0.84%) 05/11/20 Sarepta, Dyno Therapeutics to develop gene therapy vectors for muscle diseases 04/28/20 Sarepta announces research agreement with U.S. DoD for COVID-19 02/25/20 FTC grants early termination for Sarepta transaction with Vifor Pharma 01/22/20 FDA publishes CRL sent to Sarepta in August 2019 RARE Ultragenyx $64.57 / +0.44 (+0.69%) 05/13/20 Ultragenx reports results from cohorts in study of DTX301 OTC gene therapy 05/04/20 Ultragenyx, GeneTx announce Fast Track designation for GTX-102 03/31/20 Daiichi Sankyo, Ultragenyx enter gene therapy manufacturing partnership 03/31/20 Regenxbio, Ultragenyx announce worldwide license agreement for NAV AAV8/AAV9 QURE uniQure $56.16 / -0.56 (-0.99%) 05/14/20 uniQure presents preclinical data in SCA3, Fabry Disease, Hemophilia A 04/29/20 uniQure expects cash to be sufficient to fund operations into 2022 04/29/20 uniQure continuing work to resume treatment in Phase I/II trial of AMT-130 04/29/20 uniQure on track to provide data from HOPE-B trial before year-end PI Impinj $22.94 / +1.01 (+4.61%) 04/29/20 Impinj announces delay in proxy material mailing due to COVID-19 04/27/20 Impinj up 7.75% after reporting Q1 earnings results 02/13/20 Inventory chip maker Zebra falls after quarterly results hurt by China issues 02/07/20 Impinj president and COO Eric Brodersen to step down MGTA Magenta Therapeutics $8.67 / -0.305 (-3.40%) 04/16/20 Magenta Therapeutics provides business operations update amid COVID-19 outbreak 04/16/20 Magenta Therapeutics provides clinical programs update amid COVID-19 pandemic 03/17/20 Magenta Therapeutics trading resumes CTLT Catalent $70.04 / -1.08 (-1.52%) 05/04/20 Arcturus Therapeutics, Catalent announce partnership for COVID-19 vaccine 05/04/20 Catalent enters partnership with Arcturus Therapeutics 04/29/20 Catalent signs agreement with J&J to be manufacturing partner for COVID vaccine 02/24/20 Perrigo, Catalent announce FDA approval of Generic Version of ProAir HFA CRL Charles River $163.30 / +3.07 (+1.92%) 03/30/20 Charles River enters drug discovery, development partnership with Deciphex 02/13/20 Charles River CFO sells 4,500 common shares 02/11/20 Charles River 'closely monitoring' coronavirus situation 02/11/20 Charles River up 1.5% after reporting Q4 results BMRN BioMarin $91.67 / -3.01 (-3.18%) 05/03/20 BioMarin announces preclinical collaboration, license agreement with DiNAQOR 04/29/20 BioMarin: BLA for valoctocogene roxaparvovec gets FDA Priority Review 04/21/20 BioMarin names C. Greg Guyer, Ph.D., as Chief Technical Officer 04/06/20 BioMarin to submit marketing applications to FDA, EMA in Q3 for vosoritide BIO Bio-Rad $455.80 / +2.52 (+0.56%) 05/04/20 Bio-Rad gets EUA from FDA for droplet digital PCR SARS-CoV-2 test kit 04/30/20 Bio-Rad's COVID-19 serology test granted EUA by FDA 04/21/20 Bio-Rad begins shipping SARS-CoV-2 Total Ab test 04/09/20 Bio-Rad acquires Celsee, terms not disclosed AVRO Avrobio $15.58 / -1.19 (-7.10%) 05/13/20 Avrobio announces new Fabry disease, cystinosis program data at ASGCT 05/06/20 Magenta Therapeutics, Avrobio announce MGTA-117 collaboration agreement 05/04/20 Avrobio, Saladax to develop fully automated nanoparticle immunoassay kit 03/30/20 Avrobio temporarily pauses clinical trial dosing due to COVID-19 pandemic ADVM Adverum Biotechnologies $17.20 / -0.18 (-1.04%) 05/04/20 Adverum Biotechnologies reports positive vata in OPTIC ph1 trial of ADVM-022 04/27/20 Adverum Biotechnologies doses first patient in cohort 4 of OPTIC Phase 1 trial 03/13/20 Adverum Biotechnologies trading resumes 03/13/20 Adverum Biotechnologies trading halted, volatility trading pause ABEO Abeona Therapeutics $3.21 / -0.065 (-1.98%) 04/21/20 Abeona Therapeutics appoints Brian Pereira, Shawn Tomasello to board 03/27/20 Abeona Therapeutics says current clinical trial sites remain open 03/17/20 Abeona Therapeutics announces first patient treated in Phase III trial of EB-101 02/12/20 Abeona reports 'positive' interim data from MPS III gene therapy programs A Agilent $81.59 / +1.44 (+1.80%) 04/23/20 Agilent announces FDA approval of PD-L1 companion diagnostic 04/22/20 Agilent becomes sponsor of My Green Lab nonprofit 04/14/20 Agilent withdraws Q2, FY20 guidance due to COVID-19 04/06/20 Pershing boosts stake in Berkshire by 39%, Lowe's by 46% A ABEO ADVM AGEEF AVRO BIO BMRN CRL CTLT MGTA PI QURE SRPT TECH TMO RARE A Agilent $81.59 / +1.44 (+1.80%) 03/30/20 Wells Fargo Agilent price target lowered to $82 from $100 at Wells Fargo 02/24/20 Needham Agilent downgraded to Hold from Buy at Needham 02/24/20 Needham Agilent downgraded to Hold from Buy at Needham 02/19/20 Piper Sandler Agilent price target raised to $96 from $86 at Piper Sandler ABEO Abeona Therapeutics $3.21 / -0.065 (-1.98%) 05/08/20 Jefferies Abeona 'one of most underappreciated' in late-stage gene therapy, says Jefferies 12/30/19 H.C. Wainwright Abeona Therapeutics price target lowered to $11 from $15 at H.C. Wainwright 12/20/19 Cantor Fitzgerald Abeona financing to lessen takeover chartter, says Cantor Fitzgerald 12/10/19 Cantor Fitzgerald Abeona Therapeutics assumed with a Neutral at Cantor Fitzgerald ADVM Adverum Biotechnologies $17.20 / -0.18 (-1.04%) 05/12/20 RBC Capital Adverum Biotechnologies initiated with an Outperform at RBC Capital 05/05/20 SunTrust Adverum Biotechnologies upgraded to Buy from Hold at SunTrust 05/05/20 SunTrust Adverum Biotechnologies upgraded to Buy from Hold at SunTrust 04/28/20 Goldman Sachs Adverum Biotechnologies initiated with a Buy at Goldman Sachs AGEEF Halo Labs $0.00 / + (+0.00%) AVRO Avrobio $15.58 / -1.19 (-7.10%) 03/31/20 H.C. Wainwright Avrobio downgraded to Neutral from Buy at H.C. Wainwright 03/17/20 Janney Montgomery Scott Avrobio weakness a buying opportunity, says Janney Montgomery Scott 02/19/20 Nomura Instinet Avrobio price target raised to $50 from $35 at Nomura Instinet 02/11/20 Mizuho Avrobio price target raised to $35 from $28 at Mizuho BIO Bio-Rad $455.80 / +2.52 (+0.56%) 04/08/20 Jefferies Bio-Rad COVID-19 antibody test 'could be big,' says Jefferies 03/03/20 Citi Bio-Rad margin expansion story in early innings, says Citi 01/07/20 Wells Fargo Wells Fargo initiates Life Science Tools, Services, Diagnostics Sector 01/07/20 Wells Fargo Bio-Rad initiated with an Overweight at Wells Fargo BMRN BioMarin $91.67 / -3.01 (-3.18%) 05/08/20 Canaccord BioMarin price target raised to $119 from $108 at Canaccord 05/01/20 Jefferies Jefferies says valrox, vosoritide uptake may be faster than other BioMarin drugs 04/29/20 Piper Sandler BioMarin guidance cut 'transient', says Piper Sandler 04/06/20 BioMarin participates in a conference call with Stifel CRL Charles River $163.30 / +3.07 (+1.92%) 05/13/20 UBS Charles River upgraded to Buy from Neutral at UBS 05/08/20 Baird Charles River price target raised to $175 from $156 at Baird 05/08/20 SunTrust Charles River price target raised to $194 from $130 at SunTrust 04/21/20 Jefferies Jefferies downgrades Charles River to Hold after 51% rally from lows CTLT Catalent $70.04 / -1.08 (-1.52%) 05/06/20 Baird Catalent price target raised to $74 from $63 at Baird 04/29/20 Stephens Catalent deal with J&J could represent $600M revenue opportunity, says Stephens 04/20/20 RBC Capital Catalent initiated with an Outperform at RBC Capital 03/11/20 JPMorgan JPMorgan continues to recommend select exposure to Life Science Tools MGTA Magenta Therapeutics $8.67 / -0.305 (-3.40%) 01/15/20 BTIG BTIG sees 'no real reason' for Magenta Therapeutics sell-off 12/06/19 BTIG Magenta Therapeutics initiated with a Buy at BTIG 12/06/19 Goldman Sachs Magenta Therapeutics assumed with a Neutral at Goldman Sachs PI Impinj $22.94 / +1.01 (+4.61%) 04/28/20 Needham Impinj price target raised to $25 from $19 at Needham 04/28/20 Canaccord Impinj price target lowered to $35 from $40 at Canaccord 04/27/20 Piper Sandler Impinj price target lowered to $29 from $44 at Piper Sandler 03/10/20 Morgan Stanley Morgan Stanley lowers semiconductor estimates to reflect COVID-19 disruption QURE uniQure $56.16 / -0.56 (-0.99%) 03/26/20 Piper Sandler uniQure trial delay 'comes as no surprise,' says Piper Sandler 01/23/20 Cantor Fitzgerald Cantor sees further upside in uniQure, calls 'highly attractive' buyout candiate 12/10/19 Mizuho uniQure price target raised to $90 from $67 at Mizuho 12/09/19 Piper Sandler Piper says uniQure solidified 'front runner' position in Hemophilia B at ASH SRPT Sarepta $127.15 / -1.08 (-0.84%) 05/07/20 Nomura Instinet Nomura sees double in Sarepta shares, says buy on earnings selloff 04/28/20 JMP Securities JMP cautious on feasibility of Sarepta PPMO constructs being used in COVID fight 04/27/20 Citi Sarepta upcoming PPMO readout unlikely to be catalyst, says Citi 03/30/20 Mizuho Sarepta initiated with a Buy at Mizuho TECH Bio-Techne $261.68 / -0.7 (-0.27%) 05/14/20 Benchmark Benchmark sees 'multiple ways to play COVID-19' for Bio-Techne, starts at Buy 05/14/20 Benchmark Bio-Techne initiated with a Buy at Benchmark 04/20/20 Craig-Hallum Bio-Techne price target lowered to $211 from $218 at Craig-Hallum 03/30/20 Wells Fargo Bio-Techne price target lowered to $190 from $225 at Wells Fargo TMO Thermo Fisher $336.49 / +2.31 (+0.69%) 04/23/20 SVB Leerink Thermo Fisher price target raised to $365 from $330 at SVB Leerink 04/23/20 Needham Thermo Fisher price target raised to $383 from $341 at Needham 04/21/20 Wells Fargo Danaher price target raised to $170 from $155 at Wells Fargo 03/30/20 Wells Fargo Thermo Fisher price target lowered to $300 from $345 at Wells Fargo RARE Ultragenyx $64.57 / +0.44 (+0.69%) 05/13/20 Piper Sandler Ultragenyx DTX-301 update 'incrementally positive,' says Piper Sandler 01/10/20 SunTrust Ultragenyx price target raised to $80 from $75 at SunTrust 01/10/20 Piper Sandler Ultragenyx gene therapy update 'surprisingly positive,' says Piper Sandler 12/18/19 Piper Sandler Piper remains buyer of Ultragenyx after Royalty Pharma deal TMO TECH SRPT RARE QURE PI MGTA CTLT CRL BMRN BIO AVRO ADVM ABEO A TMO Thermo Fisher $336.49 / +2.31 (+0.69%) 04/22/20 Thermo Fisher reports Q1 adj. EPS $2.94, consensus $2.79 04/21/20 Notable companies reporting before tomorrow's open TECH Bio-Techne $261.68 / -0.7 (-0.27%) 04/30/20 Bio-Techne reports Q3 adj. EPS $1.39, consensus $1.15 02/04/20 Bio-Techne reports Q2 adj. EPS $1.08, consensus $1.13 SRPT Sarepta $127.15 / -1.08 (-0.84%) 05/06/20 Sarepta reports Q1 EPS (23c), consensus ($1.87) 02/26/20 Sarepta reports Q4 EPS ($1.57), consensus ($1.86) RARE Ultragenyx $64.57 / +0.44 (+0.69%) 05/06/20 Ultragenyx maintains FY20 Crysvita revenue $125M-$140M 05/06/20 Ultragenyx reports Q1 EPS ($2.05), consensus ($1.69) 02/13/20 Ultragenyx Reports Q4 revenue ($1.62), consensus ($1.65) 01/13/20 Ultragenyx sees 2020 Crysvita revenue $125M-$140M QURE uniQure $56.16 / -0.56 (-0.99%) 04/29/20 uniQure reports Q1 EPS (63c), consensus (84c) 03/02/20 uniQure had $377.8M cash position as of December 31 PI Impinj $22.94 / +1.01 (+4.61%) 04/27/20 Impinj expects end-user demand for endpoint ICs, systems 'to further decline' 04/27/20 Impinj will not give Q2 guidance 04/27/20 Impinj reports Q1 EPS 13c, consensus (6c) 03/02/20 Impinj sees 'meaningful headwind' in systems business starting in Q2 MGTA Magenta Therapeutics $8.67 / -0.305 (-3.40%) 05/07/20 Magenta Therapeutics reports Q1 EPS (51c), consensus (60c) 03/03/20 Magenta Therapeutics reports Q4 adj. EPS (59c), consensus (59c) CTLT Catalent $70.04 / -1.08 (-1.52%) 05/10/20 Fly Intel: Top five weekend stock stories 05/05/20 Catalent backs FY20 revenue view $2.78B-$2.88B, consensus $2.83B 05/05/20 Catalent reports Q3 adj. EPS 50c, consensus 48c 02/03/20 Catalent raises FY20 revenue view to $2.87B-$2.95B from $2.78B-$2.88B CRL Charles River $163.30 / +3.07 (+1.92%) 05/07/20 Charles River cuts FY20 EPS view to $6.75-$7.10 from $7.45-$7.60 05/07/20 Charles River reports Q1 EPS $1.84, consensus $1.47 02/11/20 Charles River sees FY20 EPS $7.45-$7.60, consensus $7.41 02/11/20 Charles River reports Q4 EPS $2.01, consensus $1.83 BMRN BioMarin $91.67 / -3.01 (-3.18%) 04/29/20 BioMarin cuts FY20 revenue view to $1.85B-$1.95B from $1.95B-$2.05B 04/29/20 BioMarin reports Q1 EPS 44c, may not compare to consensus 5c 02/26/20 BioMarin sees FY20 revenue $1.95B-$2.05B, consensus $1.95B 02/26/20 BioMarin reports Q4 EPS 8c, consensus (9c) BIO Bio-Rad $455.80 / +2.52 (+0.56%) 05/06/20 Bio-Rad withdraws annual guidance 05/06/20 Bio-Rad reports Q1 adjusted EPS $1.91, consensus $1.61 02/13/20 Bio-Rad sees FY20 revenue growth 4.5%-5.25%, consensus $2.42B 02/13/20 Bio-Rad reports Q4 adjusted EPS $2.32, consensus $2.44 AVRO Avrobio $15.58 / -1.19 (-7.10%) 05/07/20 Avrobio reports Q1 EPS (77c), consensus (67c) 03/30/20 Avrobio says has capital to fund into Q2 of 2022 03/16/20 Avrobio reports Q4 EPS (72c), consensus (59c) ADVM Adverum Biotechnologies $17.20 / -0.18 (-1.04%) 03/12/20 Adverum Biotechnologies reports Q4 EPS (29c), consensus (29c) ABEO Abeona Therapeutics $3.21 / -0.065 (-1.98%) 05/06/20 Abeona Therapeutics reports Q1 EPS (52c), consensus (24c) 03/16/20 Abeona Therapeutics reports Q4 EPS (30c), consensus (31c) A Agilent $81.59 / +1.44 (+1.80%) 02/18/20 Agilent backs FY20 adjusted EPS view $3.38-$3.43, consensus $3.42 02/18/20 Agilent sees Q2 adjusted EPS 72c-76c, consensus 79c 02/18/20 Agilent reports Q1 adjusted EPS 81c, consensus 81c 02/18/20 Notable companies reporting after market close TMO SRPT CTLT A TMO Thermo Fisher $336.49 / +2.31 (+0.69%) 04/05/20 Amazon, test makers in contact for potential employees' screenings, Reuters says SRPT Sarepta $127.15 / -1.08 (-0.84%) 02/25/20 Vifor confirms to Bloomberg that it purchased PRV from Sarepta 01/22/20 New documents point to 'deeper' FDA concerns about Sarepta's Vyondys, STAT says CTLT Catalent $70.04 / -1.08 (-1.52%) 05/10/20 Pfizer to outsource some drug production, focus on COVID vaccine, Reuters says A Agilent $81.59 / +1.44 (+1.80%) 02/08/20 Sustainable companies in America beating the market, Barron's says TMO SRPT PI BMRN ADVM A TMO Thermo Fisher $336.49 / +2.31 (+0.69%) 01/30/20 Rising High: An exclusive talk with product manufacturing company Valens 12/26/19 Qiagen plunges as strategic review ends with no sale SRPT Sarepta $127.15 / -1.08 (-0.84%) 05/06/20 Fly Intel: After-Hours Movers 12/13/19 Fly Intel: Wall Street's top stories for Friday 12/13/19 Fly Intel: Wall Street's top stories at midday 12/13/19 Snap upgrade, Sarepta target raises among today's top analyst actions PI Impinj $22.94 / +1.01 (+4.61%) 04/27/20 Fly Intel: After-Hours Movers 03/03/20 Fly Intel: Wall Street's top stories for Tuesday 03/03/20 Fly Intel: Wall Street's top stories at midday BMRN BioMarin $91.67 / -3.01 (-3.18%) 03/12/20 Piper sees trial disruption risk, calls out Moderna, Inovio as 'COVID-19 plays' 11/27/19 Upgrades of Under Armour, BioMarin among today's top analyst calls ADVM Adverum Biotechnologies $17.20 / -0.18 (-1.04%) 05/11/20 Fly Insider: Fennec, Becton Dickinson among week's notable insider trades A Agilent $81.59 / +1.44 (+1.80%) 02/24/20 Plethora of downgrades among today's top analyst calls 05/15/20 Ultragenyx - RARE 05/15/20 BioMarin - BMRN 05/18/20 Charles River - CRL 05/19/20 BioMarin - BMRN 05/20/20 Sarepta - SRPT 05/21/20 Agilent - A 06/18/20 PDUFA Date for Crysvita (Burosumab) 07/31/20 PDUFA Date for UX-007 08/21/20 Valoctocogene Roxaparvovec (Valrox) 05/19/20 Impinj 05/20/20 Impinj 05/20/20 Sarepta 05/20/20 Abeona Therapeutics Inc. 05/20/20 Thermo Fisher Scientific Inc. 05/27/20 BioMarin Pharmaceutical 06/04/20 AVROBIO, Inc. 06/04/20 Sarepta Therapeutics, Inc. 06/05/20 Magenta Therapeutics, Inc. 06/10/20 Impinj, Inc. TMO SRPT QURE PI BMRN A TMO Thermo Fisher $336.49 / +2.31 (+0.69%) 03/03/20 Early notable gainers among liquid option names on March 3rd SRPT Sarepta $127.15 / -1.08 (-0.84%) 12/17/19 Largest borrow rate increases among liquid names 12/13/19 Unusually active option classes on open December 13th QURE uniQure $56.16 / -0.56 (-0.99%) 01/16/20 uniQure put volume heavy and directionally bearish PI Impinj $22.94 / +1.01 (+4.61%) 04/27/20 Impinj options imply 18.9% move in share price post-earnings BMRN BioMarin $91.67 / -3.01 (-3.18%) 04/03/20 Largest borrow rate increases among liquid names 01/09/20 BioMarin call volume above normal and directionally bullish 12/12/19 BioMarin call volume above normal and directionally bullish 11/29/19 BioMarin call volume above normal and directionally bullish A Agilent $81.59 / +1.44 (+1.80%) 02/20/20 Agilent put volume heavy and directionally bearish 12/30/19 Agilent call volume above normal and directionally bullish 11/27/19 Largest borrow rate increases among liquid names
Conference/Events	American Society of Gene & Cell Therapy to hold virtual meeting » 04:55 05/14/20 05/14 04:55 05/14/20 04:55 A Agilent $80.15 / +0.32 (+0.40%) , ABEO Abeona Therapeutics $3.28 / +0.235 (+7.73%) , ADVM Adverum Biotechnologies $17.38 / -1.4 (-7.45%) , AGEEF Halo Labs $0.00 / + (+0.00%) , AVRO Avrobio $16.77 / -0.22 (-1.29%) , BIO Bio-Rad $453.28 / -8.19 (-1.77%) , BMRN BioMarin $94.68 / -1.49 (-1.55%) , CRL Charles River $160.23 / -1.16 (-0.72%) , CTLT Catalent $71.12 / + (+0.00%) , MGTA Magenta Therapeutics $8.98 / -0.4 (-4.27%) , PI Impinj $21.93 / -1.94 (-8.13%) , QURE uniQure $56.72 / -4.33 (-7.09%) , SRPT Sarepta $128.23 / -4.5 (-3.39%) , TECH Bio-Techne $262.38 / -10.54 (-3.86%) , TMO Thermo Fisher $334.18 / +2.23 (+0.67%) , RARE Ultragenyx $64.13 / -2.07 (-3.13%) 23rd Annual Virtual… 23rd Annual Virtual Meeting of ASGCT 2020 will be held May 12-15. Webcast Link ShowHide Related Items >><< Company News Street Research Earnings Periodicals On The Fly Events Options TMO TECH SRPT RARE QURE PI MGTA CTLT CRL BMRN BIO AVRO ADVM ABEO A TMO Thermo Fisher $334.18 / +2.23 (+0.67%) 05/13/20 Thermo Fisher to develop antibodies test with WuXi Diagnostics, Mayo Clinic 05/12/20 Thermo Fisher: FDA further expands EUA for multiplex real-time PCR test 05/04/20 DNA Genotek's ORAcollectRNA kit included in EUA granted to Biocerna SARS-CoV-2 04/22/20 Thermo Fisher up 3% after earnings beat, discussing COVID testing tailwinds TECH Bio-Techne $262.38 / -10.54 (-3.86%) 04/30/20 Bio-Techne announces update, develops resources for SARS-CoV-2 detection 03/25/20 Bio-Techne's Ella panel utilized in COVID-19 patient monitoring 03/18/20 Bio-Techne's Exosome Diagnostics laboratory receives contract from GSA 02/05/20 Bio-Techne announces availability of next generation ELISA kits SRPT Sarepta $128.23 / -4.5 (-3.39%) 05/11/20 Sarepta, Dyno Therapeutics to develop gene therapy vectors for muscle diseases 04/28/20 Sarepta announces research agreement with U.S. DoD for COVID-19 02/25/20 FTC grants early termination for Sarepta transaction with Vifor Pharma 01/22/20 FDA publishes CRL sent to Sarepta in August 2019 RARE Ultragenyx $64.13 / -2.07 (-3.13%) 05/13/20 Ultragenx reports results from cohorts in study of DTX301 OTC gene therapy 05/04/20 Ultragenyx, GeneTx announce Fast Track designation for GTX-102 03/31/20 Daiichi Sankyo, Ultragenyx enter gene therapy manufacturing partnership 03/31/20 Regenxbio, Ultragenyx announce worldwide license agreement for NAV AAV8/AAV9 QURE uniQure $56.72 / -4.33 (-7.09%) 04/29/20 uniQure expects cash to be sufficient to fund operations into 2022 04/29/20 uniQure continuing work to resume treatment in Phase I/II trial of AMT-130 04/29/20 uniQure on track to provide data from HOPE-B trial before year-end 04/17/20 uniQure nominates Leonard Post to board of directors PI Impinj $21.93 / -1.94 (-8.13%) 04/29/20 Impinj announces delay in proxy material mailing due to COVID-19 04/27/20 Impinj up 7.75% after reporting Q1 earnings results 02/13/20 Inventory chip maker Zebra falls after quarterly results hurt by China issues 02/07/20 Impinj president and COO Eric Brodersen to step down MGTA Magenta Therapeutics $8.98 / -0.4 (-4.27%) 04/16/20 Magenta Therapeutics provides business operations update amid COVID-19 outbreak 04/16/20 Magenta Therapeutics provides clinical programs update amid COVID-19 pandemic 03/17/20 Magenta Therapeutics trading resumes CTLT Catalent $71.12 / + (+0.00%) 05/04/20 Arcturus Therapeutics, Catalent announce partnership for COVID-19 vaccine 05/04/20 Catalent enters partnership with Arcturus Therapeutics 04/29/20 Catalent signs agreement with J&J to be manufacturing partner for COVID vaccine 02/24/20 Perrigo, Catalent announce FDA approval of Generic Version of ProAir HFA CRL Charles River $160.23 / -1.16 (-0.72%) 03/30/20 Charles River enters drug discovery, development partnership with Deciphex 02/13/20 Charles River CFO sells 4,500 common shares 02/11/20 Charles River 'closely monitoring' coronavirus situation 02/11/20 Charles River up 1.5% after reporting Q4 results BMRN BioMarin $94.68 / -1.49 (-1.55%) 05/03/20 BioMarin announces preclinical collaboration, license agreement with DiNAQOR 04/29/20 BioMarin: BLA for valoctocogene roxaparvovec gets FDA Priority Review 04/21/20 BioMarin names C. Greg Guyer, Ph.D., as Chief Technical Officer 04/06/20 BioMarin to submit marketing applications to FDA, EMA in Q3 for vosoritide BIO Bio-Rad $453.28 / -8.19 (-1.77%) 05/04/20 Bio-Rad gets EUA from FDA for droplet digital PCR SARS-CoV-2 test kit 04/30/20 Bio-Rad's COVID-19 serology test granted EUA by FDA 04/21/20 Bio-Rad begins shipping SARS-CoV-2 Total Ab test 04/09/20 Bio-Rad acquires Celsee, terms not disclosed AVRO Avrobio $16.77 / -0.22 (-1.29%) 05/13/20 Avrobio announces new Fabry disease, cystinosis program data at ASGCT 05/06/20 Magenta Therapeutics, Avrobio announce MGTA-117 collaboration agreement 05/04/20 Avrobio, Saladax to develop fully automated nanoparticle immunoassay kit 03/30/20 Avrobio temporarily pauses clinical trial dosing due to COVID-19 pandemic ADVM Adverum Biotechnologies $17.38 / -1.4 (-7.45%) 05/04/20 Adverum Biotechnologies reports positive vata in OPTIC ph1 trial of ADVM-022 04/27/20 Adverum Biotechnologies doses first patient in cohort 4 of OPTIC Phase 1 trial 03/13/20 Adverum Biotechnologies trading resumes 03/13/20 Adverum Biotechnologies trading halted, volatility trading pause ABEO Abeona Therapeutics $3.28 / +0.235 (+7.73%) 04/21/20 Abeona Therapeutics appoints Brian Pereira, Shawn Tomasello to board 03/27/20 Abeona Therapeutics says current clinical trial sites remain open 03/17/20 Abeona Therapeutics announces first patient treated in Phase III trial of EB-101 02/12/20 Abeona reports 'positive' interim data from MPS III gene therapy programs A Agilent $80.15 / +0.32 (+0.40%) 04/23/20 Agilent announces FDA approval of PD-L1 companion diagnostic 04/22/20 Agilent becomes sponsor of My Green Lab nonprofit 04/14/20 Agilent withdraws Q2, FY20 guidance due to COVID-19 04/06/20 Pershing boosts stake in Berkshire by 39%, Lowe's by 46% A ABEO ADVM AGEEF AVRO BIO BMRN CRL CTLT MGTA PI QURE SRPT TECH TMO RARE A Agilent $80.15 / +0.32 (+0.40%) 03/30/20 Wells Fargo Agilent price target lowered to $82 from $100 at Wells Fargo 02/24/20 Needham Agilent downgraded to Hold from Buy at Needham 02/24/20 Needham Agilent downgraded to Hold from Buy at Needham 02/19/20 Piper Sandler Agilent price target raised to $96 from $86 at Piper Sandler ABEO Abeona Therapeutics $3.28 / +0.235 (+7.73%) 05/08/20 Jefferies Abeona 'one of most underappreciated' in late-stage gene therapy, says Jefferies 12/30/19 H.C. Wainwright Abeona Therapeutics price target lowered to $11 from $15 at H.C. Wainwright 12/20/19 Cantor Fitzgerald Abeona financing to lessen takeover chartter, says Cantor Fitzgerald 12/10/19 Cantor Fitzgerald Abeona Therapeutics assumed with a Neutral at Cantor Fitzgerald ADVM Adverum Biotechnologies $17.38 / -1.4 (-7.45%) 05/12/20 RBC Capital Adverum Biotechnologies initiated with an Outperform at RBC Capital 05/05/20 SunTrust Adverum Biotechnologies upgraded to Buy from Hold at SunTrust 05/05/20 SunTrust Adverum Biotechnologies upgraded to Buy from Hold at SunTrust 04/28/20 Goldman Sachs Adverum Biotechnologies initiated with a Buy at Goldman Sachs AGEEF Halo Labs $0.00 / + (+0.00%) AVRO Avrobio $16.77 / -0.22 (-1.29%) 03/31/20 H.C. Wainwright Avrobio downgraded to Neutral from Buy at H.C. Wainwright 03/17/20 Janney Montgomery Scott Avrobio weakness a buying opportunity, says Janney Montgomery Scott 02/19/20 Nomura Instinet Avrobio price target raised to $50 from $35 at Nomura Instinet 02/11/20 Mizuho Avrobio price target raised to $35 from $28 at Mizuho BIO Bio-Rad $453.28 / -8.19 (-1.77%) 04/08/20 Jefferies Bio-Rad COVID-19 antibody test 'could be big,' says Jefferies 03/03/20 Citi Bio-Rad margin expansion story in early innings, says Citi 01/07/20 Wells Fargo Wells Fargo initiates Life Science Tools, Services, Diagnostics Sector 01/07/20 Wells Fargo Bio-Rad initiated with an Overweight at Wells Fargo BMRN BioMarin $94.68 / -1.49 (-1.55%) 05/08/20 Canaccord BioMarin price target raised to $119 from $108 at Canaccord 05/01/20 Jefferies Jefferies says valrox, vosoritide uptake may be faster than other BioMarin drugs 04/29/20 Piper Sandler BioMarin guidance cut 'transient', says Piper Sandler 04/06/20 BioMarin participates in a conference call with Stifel CRL Charles River $160.23 / -1.16 (-0.72%) 05/13/20 UBS Charles River upgraded to Buy from Neutral at UBS 05/08/20 Baird Charles River price target raised to $175 from $156 at Baird 05/08/20 SunTrust Charles River price target raised to $194 from $130 at SunTrust 04/21/20 Jefferies Jefferies downgrades Charles River to Hold after 51% rally from lows CTLT Catalent $71.12 / + (+0.00%) 05/06/20 Baird Catalent price target raised to $74 from $63 at Baird 04/29/20 Stephens Catalent deal with J&J could represent $600M revenue opportunity, says Stephens 04/20/20 RBC Capital Catalent initiated with an Outperform at RBC Capital 03/11/20 JPMorgan JPMorgan continues to recommend select exposure to Life Science Tools MGTA Magenta Therapeutics $8.98 / -0.4 (-4.27%) 01/15/20 BTIG BTIG sees 'no real reason' for Magenta Therapeutics sell-off 12/06/19 BTIG Magenta Therapeutics initiated with a Buy at BTIG 12/06/19 Goldman Sachs Magenta Therapeutics assumed with a Neutral at Goldman Sachs PI Impinj $21.93 / -1.94 (-8.13%) 04/28/20 Needham Impinj price target raised to $25 from $19 at Needham 04/28/20 Canaccord Impinj price target lowered to $35 from $40 at Canaccord 04/27/20 Piper Sandler Impinj price target lowered to $29 from $44 at Piper Sandler 03/10/20 Morgan Stanley Morgan Stanley lowers semiconductor estimates to reflect COVID-19 disruption QURE uniQure $56.72 / -4.33 (-7.09%) 03/26/20 Piper Sandler uniQure trial delay 'comes as no surprise,' says Piper Sandler 01/23/20 Cantor Fitzgerald Cantor sees further upside in uniQure, calls 'highly attractive' buyout candiate 12/10/19 Mizuho uniQure price target raised to $90 from $67 at Mizuho 12/09/19 Piper Sandler Piper says uniQure solidified 'front runner' position in Hemophilia B at ASH SRPT Sarepta $128.23 / -4.5 (-3.39%) 05/07/20 Nomura Instinet Nomura sees double in Sarepta shares, says buy on earnings selloff 04/28/20 JMP Securities JMP cautious on feasibility of Sarepta PPMO constructs being used in COVID fight 04/27/20 Citi Sarepta upcoming PPMO readout unlikely to be catalyst, says Citi 03/30/20 Mizuho Sarepta initiated with a Buy at Mizuho TECH Bio-Techne $262.38 / -10.54 (-3.86%) 04/20/20 Craig-Hallum Bio-Techne price target lowered to $211 from $218 at Craig-Hallum 03/30/20 Wells Fargo Bio-Techne price target lowered to $190 from $225 at Wells Fargo 02/24/20 Eight Capital Bio-Techne downgraded to Neutral from Buy at Eight Capital 01/08/20 Stephens Bio-Techne resumed with an Overweight at Stephens TMO Thermo Fisher $334.18 / +2.23 (+0.67%) 04/23/20 SVB Leerink Thermo Fisher price target raised to $365 from $330 at SVB Leerink 04/23/20 Needham Thermo Fisher price target raised to $383 from $341 at Needham 04/21/20 Wells Fargo Danaher price target raised to $170 from $155 at Wells Fargo 03/30/20 Wells Fargo Thermo Fisher price target lowered to $300 from $345 at Wells Fargo RARE Ultragenyx $64.13 / -2.07 (-3.13%) 05/13/20 Piper Sandler Ultragenyx DTX-301 update 'incrementally positive,' says Piper Sandler 01/10/20 SunTrust Ultragenyx price target raised to $80 from $75 at SunTrust 01/10/20 Piper Sandler Ultragenyx gene therapy update 'surprisingly positive,' says Piper Sandler 12/18/19 Piper Sandler Piper remains buyer of Ultragenyx after Royalty Pharma deal TMO TECH SRPT RARE QURE PI MGTA CTLT CRL BMRN BIO AVRO ADVM ABEO A TMO Thermo Fisher $334.18 / +2.23 (+0.67%) 04/22/20 Thermo Fisher reports Q1 adj. EPS $2.94, consensus $2.79 04/21/20 Notable companies reporting before tomorrow's open TECH Bio-Techne $262.38 / -10.54 (-3.86%) 04/30/20 Bio-Techne reports Q3 adj. EPS $1.39, consensus $1.15 02/04/20 Bio-Techne reports Q2 adj. EPS $1.08, consensus $1.13 SRPT Sarepta $128.23 / -4.5 (-3.39%) 05/06/20 Sarepta reports Q1 EPS (23c), consensus ($1.87) 02/26/20 Sarepta reports Q4 EPS ($1.57), consensus ($1.86) RARE Ultragenyx $64.13 / -2.07 (-3.13%) 05/06/20 Ultragenyx maintains FY20 Crysvita revenue $125M-$140M 05/06/20 Ultragenyx reports Q1 EPS ($2.05), consensus ($1.69) 02/13/20 Ultragenyx Reports Q4 revenue ($1.62), consensus ($1.65) 01/13/20 Ultragenyx sees 2020 Crysvita revenue $125M-$140M QURE uniQure $56.72 / -4.33 (-7.09%) 04/29/20 uniQure reports Q1 EPS (63c), consensus (84c) 03/02/20 uniQure had $377.8M cash position as of December 31 PI Impinj $21.93 / -1.94 (-8.13%) 04/27/20 Impinj expects end-user demand for endpoint ICs, systems 'to further decline' 04/27/20 Impinj will not give Q2 guidance 04/27/20 Impinj reports Q1 EPS 13c, consensus (6c) 03/02/20 Impinj sees 'meaningful headwind' in systems business starting in Q2 MGTA Magenta Therapeutics $8.98 / -0.4 (-4.27%) 05/07/20 Magenta Therapeutics reports Q1 EPS (51c), consensus (60c) 03/03/20 Magenta Therapeutics reports Q4 adj. EPS (59c), consensus (59c) CTLT Catalent $71.12 / + (+0.00%) 05/10/20 Fly Intel: Top five weekend stock stories 05/05/20 Catalent backs FY20 revenue view $2.78B-$2.88B, consensus $2.83B 05/05/20 Catalent reports Q3 adj. EPS 50c, consensus 48c 02/03/20 Catalent raises FY20 revenue view to $2.87B-$2.95B from $2.78B-$2.88B CRL Charles River $160.23 / -1.16 (-0.72%) 05/07/20 Charles River cuts FY20 EPS view to $6.75-$7.10 from $7.45-$7.60 05/07/20 Charles River reports Q1 EPS $1.84, consensus $1.47 02/11/20 Charles River sees FY20 EPS $7.45-$7.60, consensus $7.41 02/11/20 Charles River reports Q4 EPS $2.01, consensus $1.83 BMRN BioMarin $94.68 / -1.49 (-1.55%) 04/29/20 BioMarin cuts FY20 revenue view to $1.85B-$1.95B from $1.95B-$2.05B 04/29/20 BioMarin reports Q1 EPS 44c, may not compare to consensus 5c 02/26/20 BioMarin sees FY20 revenue $1.95B-$2.05B, consensus $1.95B 02/26/20 BioMarin reports Q4 EPS 8c, consensus (9c) BIO Bio-Rad $453.28 / -8.19 (-1.77%) 05/06/20 Bio-Rad withdraws annual guidance 05/06/20 Bio-Rad reports Q1 adjusted EPS $1.91, consensus $1.61 02/13/20 Bio-Rad sees FY20 revenue growth 4.5%-5.25%, consensus $2.42B 02/13/20 Bio-Rad reports Q4 adjusted EPS $2.32, consensus $2.44 AVRO Avrobio $16.77 / -0.22 (-1.29%) 05/07/20 Avrobio reports Q1 EPS (77c), consensus (67c) 03/30/20 Avrobio says has capital to fund into Q2 of 2022 03/16/20 Avrobio reports Q4 EPS (72c), consensus (59c) ADVM Adverum Biotechnologies $17.38 / -1.4 (-7.45%) 03/12/20 Adverum Biotechnologies reports Q4 EPS (29c), consensus (29c) ABEO Abeona Therapeutics $3.28 / +0.235 (+7.73%) 05/06/20 Abeona Therapeutics reports Q1 EPS (52c), consensus (24c) 03/16/20 Abeona Therapeutics reports Q4 EPS (30c), consensus (31c) A Agilent $80.15 / +0.32 (+0.40%) 02/18/20 Agilent backs FY20 adjusted EPS view $3.38-$3.43, consensus $3.42 02/18/20 Agilent sees Q2 adjusted EPS 72c-76c, consensus 79c 02/18/20 Agilent reports Q1 adjusted EPS 81c, consensus 81c 02/18/20 Notable companies reporting after market close TMO SRPT CTLT A TMO Thermo Fisher $334.18 / +2.23 (+0.67%) 04/05/20 Amazon, test makers in contact for potential employees' screenings, Reuters says SRPT Sarepta $128.23 / -4.5 (-3.39%) 02/25/20 Vifor confirms to Bloomberg that it purchased PRV from Sarepta 01/22/20 New documents point to 'deeper' FDA concerns about Sarepta's Vyondys, STAT says CTLT Catalent $71.12 / + (+0.00%) 05/10/20 Pfizer to outsource some drug production, focus on COVID vaccine, Reuters says A Agilent $80.15 / +0.32 (+0.40%) 02/08/20 Sustainable companies in America beating the market, Barron's says TMO SRPT PI BMRN ADVM A TMO Thermo Fisher $334.18 / +2.23 (+0.67%) 01/30/20 Rising High: An exclusive talk with product manufacturing company Valens 12/26/19 Qiagen plunges as strategic review ends with no sale SRPT Sarepta $128.23 / -4.5 (-3.39%) 05/06/20 Fly Intel: After-Hours Movers 12/13/19 Fly Intel: Wall Street's top stories for Friday 12/13/19 Fly Intel: Wall Street's top stories at midday 12/13/19 Snap upgrade, Sarepta target raises among today's top analyst actions PI Impinj $21.93 / -1.94 (-8.13%) 04/27/20 Fly Intel: After-Hours Movers 03/03/20 Fly Intel: Wall Street's top stories for Tuesday 03/03/20 Fly Intel: Wall Street's top stories at midday BMRN BioMarin $94.68 / -1.49 (-1.55%) 03/12/20 Piper sees trial disruption risk, calls out Moderna, Inovio as 'COVID-19 plays' 11/27/19 Upgrades of Under Armour, BioMarin among today's top analyst calls ADVM Adverum Biotechnologies $17.38 / -1.4 (-7.45%) 05/11/20 Fly Insider: Fennec, Becton Dickinson among week's notable insider trades A Agilent $80.15 / +0.32 (+0.40%) 02/24/20 Plethora of downgrades among today's top analyst calls 05/15/20 Ultragenyx - RARE 05/15/20 BioMarin - BMRN 05/19/20 BioMarin - BMRN 05/20/20 Sarepta - SRPT 05/21/20 Agilent - A 06/18/20 PDUFA Date for Crysvita (Burosumab) 07/31/20 PDUFA Date for UX-007 08/21/20 Valoctocogene Roxaparvovec (Valrox) 05/19/20 Impinj 05/20/20 Impinj 05/20/20 Sarepta 05/20/20 Abeona Therapeutics Inc. 05/20/20 Thermo Fisher Scientific Inc. 05/27/20 BioMarin Pharmaceutical 06/04/20 AVROBIO, Inc. 06/04/20 Sarepta Therapeutics, Inc. 06/05/20 Magenta Therapeutics, Inc. 06/10/20 Impinj, Inc. TMO SRPT QURE PI BMRN A TMO Thermo Fisher $334.18 / +2.23 (+0.67%) 03/03/20 Early notable gainers among liquid option names on March 3rd SRPT Sarepta $128.23 / -4.5 (-3.39%) 12/17/19 Largest borrow rate increases among liquid names 12/13/19 Unusually active option classes on open December 13th QURE uniQure $56.72 / -4.33 (-7.09%) 01/16/20 uniQure put volume heavy and directionally bearish PI Impinj $21.93 / -1.94 (-8.13%) 04/27/20 Impinj options imply 18.9% move in share price post-earnings BMRN BioMarin $94.68 / -1.49 (-1.55%) 04/03/20 Largest borrow rate increases among liquid names 01/09/20 BioMarin call volume above normal and directionally bullish 12/12/19 BioMarin call volume above normal and directionally bullish 11/29/19 BioMarin call volume above normal and directionally bullish A Agilent $80.15 / +0.32 (+0.40%) 02/20/20 Agilent put volume heavy and directionally bearish 12/30/19 Agilent call volume above normal and directionally bullish 11/27/19 Largest borrow rate increases among liquid names

On The Fly

News and insights, exclusive to thefly.com

10:36	Muddy Waters questions eHealth revenue collection in renewed short attack»
10:08	Fly Intel: Top five analyst initiations»
10:08	Fly Intel: Top five analyst downgrades»
10:08	Fly Intel: Top five analyst upgrades»
09:36	Tiffany hasn't heard from LVMH about any deal issues, CNBC reports»

View all On The Fly Stories »

Upcoming
Events (10)

DXPE	DXP Enterprises - DXPE
ITI	Iteris - ITI
BHE	Benchmark Electronics - BHE
DBD	Diebold - DBD
MATW	Matthews - MATW
HLIO	Helios Technologies - HLIO
GNK	Genco Shipping - GNK
CNXN	Connection - CNXN
KLIC	Kulicke & Soffa - KLIC
IRDM	Iridium - IRDM

View all of today’s events »

Today’s
Syndicate (10)

SPCE	Block Trade
PLRX	IPO
WMG	IPO
DT	Secondary
NTLA	Secondary
OSUR	Secondary
ARCE	Spot Secondary
EVFM	Spot Secondary
HLNE	Spot Secondary
RNR	Spot Secondary

View this week’s syndicate »

Get Full Fly Access

Breaking market intelligence sent straight to you: Our team of experts analyze every news story and filter out the noise to deliver real-time market moving news.

Up-to-date information on important industry events: Get real-time updates on events that are moving the market—from conferences and calls to syndicate announcements.

News focused on the companies in your portfolio: Create up to 12 portfolios with 150 stocks each, and see how active they are in market news.

14 Day Free Trial